Document:

Exhibit 10.1

 

Execution Version

 

CCO HOLDINGS, LLC 

CCO HOLDINGS CAPITAL CORP.

 

4.500% SENIOR NOTES DUE 2033

 

EXCHANGE AND REGISTRATION RIGHTS AGREEMENT

 

June 2, 2021

 

Deutsche Bank Securities Inc.

As representative (“Representative”) of the Purchasers

 

	c/o	Deutsche Bank Securities Inc.

60 Wall Street

New York, New York 10005

 

 

Ladies and Gentlemen:

 

CCO Holdings, LLC, a Delaware limited liability company
(the “Company”), and CCO Holdings Capital Corp., a Delaware corporation (together with the Company, the “Issuers”),
propose, subject to the terms and conditions stated herein, to issue and sell to the Purchasers (as defined herein) upon the terms set
forth in the Purchase Agreement (as defined herein) $750,000,000 aggregate principal amount of their 4.500% Senior Notes due 2033 (the
 “Notes”) on June 2, 2021. In satisfaction of a condition to the obligations of the Purchasers under the Purchase Agreement,
the Issuers agree with the Purchasers for the benefit of holders (as defined herein) from time to time of the Registrable Securities (as
defined herein) as follows:

 

SECTION
1.           Certain Definitions. For purposes of this Exchange and Registration
Rights Agreement, the following terms shall have the following respective meanings:

 

“Agreement” shall mean this Exchange
and Registration Rights Agreement.

 

“Base Indenture” shall mean the
Indenture, dated as of May 23, 2019, among the Issuers and the Trustee.

 

“Base Interest” shall mean the
interest that would otherwise accrue on the Notes under the terms thereof and the Indenture, without giving effect to the provisions of
this Agreement.

 

“broker-dealer” shall mean any
broker or dealer registered with the Commission under the Exchange Act.

 

     

     

    

 

“CCH II” means CCH II, LLC, a
Delaware limited liability company.

 

“Charter” shall mean Charter Communications
Inc., a Delaware corporation.

 

“Charter Holdings” shall mean
Charter Communications Holdings, LLC, a Delaware limited liability company.

 

“Closing Date” shall mean June
2, 2021.

 

“Commission” shall mean the United
States Securities and Exchange Commission, or any other federal agency at the time administering the Exchange Act or the Securities Act,
whichever is the relevant statute for the particular purpose.

 

“Company” shall have the meaning
assigned thereto in the introductory paragraph hereto.

 

“Conduct Rules” shall have the
meaning assigned thereto in Section 3(e)(xix) hereof.

 

“Effective Time,” in the case
of (i) an Exchange Offer Registration, shall mean the time and date as of which the Commission declares the Exchange Offer Registration
Statement effective or as of which the Exchange Offer Registration Statement otherwise becomes effective and (ii) a Shelf Registration,
shall mean the time and date as of which the Commission declares the Shelf Registration Statement effective or as of which the Shelf Registration
Statement otherwise becomes effective.

 

“Electing Holder” shall mean any
holder of Registrable Securities that has returned a completed and signed Notice and Questionnaire to the Issuers in accordance with Section
3(e)(ii) or 3(e)(iii) hereof.

 

“Exchange Act” shall mean the
Securities Exchange Act of 1934, or any successor thereto, and the rules, regulations and forms promulgated thereunder, all as the same
shall be amended from time to time.

 

“Exchange Date” shall have the
meaning assigned thereto in Section 2(a) hereof.

 

“Exchange Notes” shall mean the
senior notes issued by the Issuers under the Indenture substantially identical in all material respects to the Notes (and entitled to
the benefits of the Indenture which shall be qualified under the Trust Indenture Act), except that they have been registered pursuant
to an effective registration statement under the Securities Act and do not contain provisions for the additional interest contemplated
in Section 2(c) hereof, to be issued to holders in exchange for Registrable Securities.

 

“Exchange Offer” shall have the
meaning assigned thereto in Section 2(a) hereof.

 

“Exchange Offer Registration”
shall have the meaning assigned thereto in Section 3(c) hereof.

 

    -2-

     

    

 

“Exchange Offer Registration Statement”
shall have the meaning assigned thereto in Section 2(a) hereof.

 

“Exchanging Dealer” shall have
the meaning assigned thereto in Section 6(a) hereof.

 

“FINRA” shall have the meaning
assigned thereto in Section 3(e)(xix) hereof.

 

“holder” shall mean, unless the
context otherwise indicates, each of the Purchasers and other persons who acquire Registrable Securities from time to time (including,
without limitation, any successors or assigns), in each case for so long as such person is a registered holder of any Registrable Securities.

 

“Indenture” shall mean the Base
Indenture, as supplemented by the Sixth Supplemental Indenture (as defined below), as the same shall be amended or supplemented from time
to time.

 

“Issuers” shall have the meaning
assigned thereto in the introductory paragraph hereto.

 

“Losses” shall have the meaning
assigned thereto in Section 6(d) hereof.

 

“Notes” shall have the meaning
assigned thereto in the introductory paragraph hereto and shall include any Notes issued in exchange therefor or in lieu thereof pursuant
to the Indenture.

 

“Notice and Questionnaire” shall
mean a Notice of Registration Statement and Selling Securityholder Questionnaire substantially in the form of Exhibit A hereto.

 

“Parent Companies” shall mean,
collectively, (i) Charter, (ii) Charter Holdings, (iii) Charter Communications Holding Company, LLC, a Delaware limited liability
company, and (iv) CCH II.

 

“person” shall mean a corporation,
association, partnership, organization, limited liability company, business, individual, government or political subdivision thereof or
governmental agency.

 

“Purchase Agreement” shall mean
the Purchase Agreement, dated May 18, 2021, among the Representative and the Issuers, relating to the Notes.

 

“Purchasers” shall mean the Purchasers
named in Schedule I to the Purchase Agreement.

 

    -3-

     

    

 

“Registrable Securities”
shall mean the Notes (and to the extent set forth in clause (i) of this definition and in Section 2(d) hereof, certain Exchange
Notes); provided, however, that a Note or Exchange Note shall cease to be a Registrable Security when (i) in the
circumstances contemplated by Section 2(a) hereof, such Note has been exchanged for an Exchange Note in an Exchange Offer as
contemplated in Section 2(a) hereof (provided that any Exchange Note that, pursuant to the penultimate sentence of Section
2(a), is included in a prospectus for use in connection with resales by broker-dealers shall be deemed to be a Registrable Security
with respect to Sections 5, 6 and 9 hereof until resale of such Registrable Security has been effected within the 180-day period
referred to in Section 2(a)(y)); (ii) in the circumstances contemplated by Section 2(b) hereof, a Shelf Registration Statement
registering such Note or Exchange Note under the Securities Act has been declared or becomes effective and such Note or Exchange
Note has been sold or otherwise transferred by the holder thereof pursuant to and in a manner contemplated by such effective Shelf
Registration Statement; (iii) such Note or Exchange Note is sold pursuant to Rule 144 under circumstances in which any legend borne
by such Note or Exchange Note relating to restrictions on transferability thereof, under the Securities Act or otherwise, is removed
by the Issuers pursuant to the Indenture; (iv) such Note or Exchange Note is eligible to be sold pursuant to Rule 144 by a Person
that is not an “affiliate” (within the meaning of Rule 405); or (v) such Note or Exchange Note shall cease to be
outstanding.

 

“Registration Default” shall have
the meaning assigned thereto in Section 2(c) hereof.

 

“Registration Default Period”
shall have the meaning assigned thereto in Section 2(c) thereof.

 

“Registration Expenses” shall
have the meaning assigned thereto in Section 4 hereof.

 

“Representative” shall have the
meaning assigned thereto in the addressee block hereto.

 

“Resale Period” shall have the
meaning assigned thereto in Section 2(a) hereof.

 

“Restricted Holder” shall mean
(i) a holder that is an affiliate of the Issuers within the meaning of Rule 405, (ii) a holder who acquires Exchange Notes outside the
ordinary course of such holder’s business, (iii) a holder who has arrangements or understandings with any person to participate
in the Exchange Offer for the purpose of distributing Exchange Notes and (iv) a holder that is a broker-dealer, but only with respect
to Exchange Notes received by such broker-dealer pursuant to an Exchange Offer in exchange for Registrable Securities acquired by the
broker-dealer directly from the Issuers.

 

“Rule 144,” “Rule 405”
and “Rule 415” shall mean, in each case, such rule promulgated under the Securities Act (or any successor provision),
as the same shall be amended from time to time.

 

“Securities Act” shall mean the
Securities Act of 1933, or any successor thereto, and the rules, regulations and forms promulgated thereunder, all as the same shall be
amended from time to time.

 

“Shelf Filing Deadline” shall
have the meaning assigned thereto in Section 2(b) hereof.

 

    -4-

     

    

 

“Shelf Registration” shall have
the meaning assigned thereto in Section 2(b) hereof.

 

“Shelf Registration Statement”
shall have the meaning assigned thereto in Section 2(b) hereof.

 

“Sixth Supplemental Indenture”
shall mean the sixth supplemental indenture to the Base Indenture, dated as of April 22, 2021, by and among the Issuers and the Trustee,
relating to the Notes.

 

“Special Interest” shall have
the meaning assigned thereto in Section 2(c) hereof.

 

“Transfer Restricted Notes” shall
have the meaning assigned thereto in Section 2(c) hereof.

 

“Trust Indenture Act” shall mean
the Trust Indenture Act of 1939, or any successor thereto, and the rules, regulations and forms promulgated thereunder, all as the same
shall be amended from time to time.

 

“Trustee” shall mean The Bank
of New York Mellon Trust Company, N.A., as trustee under the Indenture.

 

Unless the context otherwise requires, any reference
herein to a “Section” or “clause” refers to a Section or clause, as the case may be, of this Agreement, and the
words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Agreement
as a whole and not to any particular Section or other subdivision. Any reference herein to “Notes” or “Exchange Notes”
refers also to any guarantees thereof by any guarantors required to guarantee such notes pursuant to the Indenture.

 

SECTION
2.           Registration Under the Securities Act.

 

(a)               Except
as set forth in Section 2(b) below, the Issuers agree to file under the Securities Act, as soon as practicable, a registration
statement relating to an offer to exchange (such registration statement, the “Exchange Offer Registration
Statement,” and such offer, the “Exchange Offer”) any and all Registrable Securities for a like
aggregate principal amount of Exchange Notes. The Issuers agree to use their reasonable best efforts to cause the Exchange Offer
Registration Statement to become or be declared effective under the Securities Act as soon as practicable after the Closing Date.
The Exchange Offer will be registered under the Securities Act on the appropriate form and will comply with the Exchange Act. The
Issuers further agree to use their reasonable best efforts to complete the Exchange Offer not later than 450 days following April
22, 2021 (or if such 450th day is not a business day, the next succeeding business day) (the “Exchange
Date”) and to exchange Exchange Notes for all Registrable Securities that have been properly tendered and not withdrawn on
or prior to the expiration of the Exchange Offer. The Issuers shall keep the Exchange Offer open for a period of not less than the
minimum period required under applicable United States federal and state securities laws to complete the Exchange Offer; provided, however,
that in no event shall such period be less than 20 business days after the date notice of the Exchange Offer is mailed to holders.
The Exchange Offer will be deemed to have been completed only if the Exchange Notes received by holders, other than Restricted
Holders, in the Exchange Offer in exchange for Registrable Securities are, upon receipt, transferable by each such holder without
restriction under the Securities Act and the Exchange Act and without material restrictions under the blue sky or securities laws of
a substantial majority of the States of the United States of America. The Exchange Offer shall be deemed to have been completed upon
the earlier to occur of (i) the Issuers having exchanged the Exchange Notes for all outstanding Registrable Securities pursuant to
the Exchange Offer and (ii) the Issuers having exchanged, pursuant to the Exchange Offer, Exchange Notes for all Registrable
Securities that have been properly tendered and not withdrawn before the expiration of the Exchange Offer. The Issuers agree (x) to
include in the Exchange Offer Registration Statement a prospectus for use in any resales by any holder of Exchange Notes that is a
broker-dealer and identifies itself as such by written notice to the Issuers prior to the effectiveness of the Exchange Offer
Registration Statement and (y) to keep such Exchange Offer Registration Statement effective for a period (the “Resale
Period”) beginning when Exchange Notes are first issued in the Exchange Offer and ending upon the earlier of the
expiration of the 180th day after the Exchange Offer has been completed or such time as such broker-dealers no longer own any
Registrable Securities. With respect to such Exchange Offer Registration Statement, such holders shall have the benefit of the
rights of indemnification and contribution set forth in Sections 6(a), (c), (d) and (e) hereof.

 

    -5-

     

    

 

(b)               If
(i) on or prior to the time the Exchange Offer is completed existing law or Commission policy or interpretations are changed such
that the Exchange Notes received by holders, other than Restricted Holders, in the Exchange Offer in exchange for Registrable
Securities are not or would not be, upon receipt, transferable by each such holder without restriction under the Securities Act,
(ii) the Exchange Offer has not been completed by the Exchange Date, (iii) any Purchaser so requests with respect to Registrable
Securities that are not eligible to be exchanged for Exchange Notes in the Exchange Offer and that are held by it following the
consummation of the Exchange Offer, or (iv) the Exchange Offer is not available to any holder (other than a Purchaser) which
notifies the Issuers in writing, then, in each case, the Issuers shall, in lieu of (or, in the case of clause (iii) or (iv), in
addition to) conducting the Exchange Offer contemplated by Section 2(a), file a “shelf” registration statement in
accordance with the remainder of this Section 2(b) below, under the Securities Act with respect to the Notes that could not be
exchanged for any reason set forth in clauses (i) through (iv) above. The Issuers shall, on or prior to 30 business days after the
time such obligation to file arises, file a “shelf” registration statement providing for the registration of, and the
sale on a continuous or delayed basis by the holders of, all the Registrable Securities, pursuant to Rule 415 or any similar rule
that may be adopted by the Commission (such filing, the “Shelf Registration” and such registration statement, the
 “Shelf Registration Statement”). The Issuers agree to use their reasonable best efforts (x) to cause the Shelf
Registration Statement to become or be declared effective by the Commission on or prior to the later of 450 days (or if such 450th
day is not a business day, the next succeeding business day) following the April 22, 2021 and the 90th day (or if such 90th day is
not a business day, the next succeeding business day) after the date such filing obligations arises (the “Shelf Filing
Deadline”) and to keep such Shelf Registration Statement continuously effective for a period ending on the earlier of (i)
the second anniversary of the Effective Time or (ii) such time as there are no longer any Registrable Securities outstanding; provided, however,
that no holder (other than a Purchaser) shall be entitled to be named as a selling securityholder in the Shelf Registration
Statement or to use the prospectus forming a part thereof for resales of Registrable Securities unless such holder is an Electing
Holder, and (y) after the Effective Time of the Shelf Registration Statement, promptly upon the request of any holder of Registrable
Securities that is not then an Electing Holder, to take any action reasonably necessary to enable such holder to use the prospectus
forming a part thereof for resales of Registrable Securities, including, without limitation, any action necessary to identify such
holder as a selling securityholder in the Shelf Registration Statement; provided, however, that nothing in this clause
(y) shall relieve any such holder of the obligation to return a completed and signed Notice and Questionnaire to the Issuers in
accordance with Section 3(e)(iii) hereof. The Issuers further agree to supplement or make amendments to the Shelf Registration
Statement, as and when required by the rules, regulations or instructions applicable to the registration form used by the Issuers
for such Shelf Registration Statement or by the Securities Act for shelf registration, and the Issuers agree to furnish to each
Electing Holder copies of any such supplement or amendment prior to its being used or promptly following its filing with the
Commission.

 

    -6-

     

    

 

(c)               In
the event that (i) the Shelf Registration Statement has not become effective or been declared effective by the Commission on or
prior to the Shelf Filing Deadline, (ii) the Exchange Offer has not been completed on or prior to the Exchange Date, (iii) the
Exchange Offer Registration Statement required by Section 2(a) hereof is filed and becomes or is declared effective but thereafter
shall either be withdrawn by the Issuers or shall become subject to an effective stop order issued pursuant to Section 8(d) of the
Securities Act suspending the effectiveness of such registration statement (except as specifically permitted herein) without being
succeeded immediately by an additional registration statement filed and declared effective, in each case prior to the completion of
the Exchange Offer or (iv) the Shelf Registration Statement required by Section 2(b) hereof is filed and becomes or is declared
effective but shall thereafter either be withdrawn by the Issuers or shall become subject to an effective stop order issued pursuant
to Section 8(d) of the Securities Act suspending the effectiveness of such registration statement (except as specifically permitted
herein) without being succeeded immediately by an additional registration statement filed and declared effective (each such event
referred to in clauses (i) through (iv), a “Registration Default” and each period during which a Registration
Default has occurred and is continuing, a “Registration Default Period”), then, as liquidated damages for such
Registration Default, subject to the provisions of Section 9(b), special interest (“Special Interest”), in
addition to the Base Interest, shall accrue on the aggregate principal amount of the outstanding Transfer Restricted Notes (as
defined below) affected by such Registration Default at a per annum rate of 0.25% for the first 90 days of the Registration Default
Period and at a per annum rate of 0.50% thereafter for the remaining portion of the Registration Default Period, commencing on (A)
the 90th day after the filing of such Shelf Registration Statement was required, in the case of clause (i) above (but in no event
prior to the 450th day after April 22, 2021), (B) the 450th day after April 22, 2021, in the case of clause
(ii) above, (C) the day such Exchange Offer Registration Statement ceases to be effective, in the case of clause (iii) above and (D)
the day such Shelf Registration Statement ceases to be effective, in the case of clause (iv) above. Following the cure of all
Registration Defaults relating to particular Transfer Restricted Notes (which shall be the Effective Time of the Shelf Registration
Statement in the case of clause (i) above, the date of the completion of the Exchange Offer, in the case of clause (ii) above, the
date that the Exchange Offer Registration Statement again becomes effective, in the case of clause (iii) above, and the date that
the Shelf Registration Statement again becomes effective, in the case of clause (iv) above), the interest rate borne by the relevant
Transfer Restricted Notes will be reduced to the original interest rate borne by such Transfer Restricted Notes; provided, however,
that, if after any such reduction in interest rate, a different Registration Default occurs, the interest rate borne by the relevant
Transfer Restricted Notes shall again be increased pursuant to the foregoing provisions. All accrued Special Interest shall be paid
in cash by the Issuers on each Interest Payment Date (as defined in the Indenture). For purposes of this Agreement,
 “Transfer Restricted Notes” shall mean, with respect to any Registration Default, any Notes or Exchange Notes
which have not ceased being Registrable Securities pursuant to the definition thereof in Section 1 of this Agreement.
Notwithstanding anything contained herein, Special Interest shall be the sole and exclusive remedy with respect to a Registration
Default.

 

    -7-

     

    

 

(d)              
If any Purchaser determines that it is not eligible to participate in the Exchange Offer with respect to the exchange of Registrable
Securities constituting any portion of an unsold allotment, at the request of such Purchaser, then, subject to any prohibitions or restrictions
imposed by any applicable law or regulations, the Issuers shall use their commercially reasonable efforts to issue and deliver to such
Purchaser, in exchange for such Registrable Securities, a like principal amount of Exchange Notes. Such issuance shall not be deemed to
be part of the Exchange Offer. The Issuers shall use their commercially reasonable efforts to cause the CUSIP Service Bureau to issue
the same CUSIP number for Exchange Notes described in this Section 2(d) as for Exchange Notes issued pursuant to the Exchange Offer. Any
such Exchange Notes shall, at the time of issuance, and subject to the limitations set forth in Section 1 hereof, constitute Registrable
Securities for purposes of this Agreement (other than Section 2(a) hereof).

 

(e)              
The Issuers shall use their reasonable best efforts to take all actions necessary or advisable to be taken by them to ensure that
the transactions contemplated herein are effected as so contemplated in Section 2(a) or 2(b) hereof.

 

(f)               
Any reference herein to a registration statement as of any time shall be deemed to include any document incorporated, or deemed
to be incorporated, therein by reference as of such time and any reference herein to any post-effective amendment to a registration statement
as of any time shall be deemed to include any document incorporated, or deemed to be incorporated, therein by reference as of such time.

 

SECTION
3.           Registration Procedures. If the Issuers file a registration
statement pursuant to Section 2(a) or Section 2(b), the following provisions shall apply:

 

(a)              
At or before the Effective Time of the Exchange Offer or the Shelf Registration, as the case may be, the Issuers shall cause the
Indenture to be qualified under the Trust Indenture Act of 1939.

 

(b)              
In the event that such qualification would require the appointment of a new trustee under the Indenture, the Issuers shall appoint
a new trustee thereunder pursuant to the applicable provisions of the Indenture.

 

(c)              
In connection with the Issuers’ obligations with respect to the registration of Exchange Notes as contemplated by Section
2(a) (the “Exchange Offer Registration”), if applicable, the Issuers shall, as soon as practicable (or as otherwise
specified):

 

    -8-

     

    

 

(i)         
 prepare and file with the Commission an Exchange Offer Registration Statement on any form which may be utilized by the Issuers and which
shall permit the Exchange Offer and resales of Exchange Notes by broker-dealers during the Resale Period to be effected as contemplated
by Section 2(a);

 

(ii)         as soon as practicable prepare and file with
the Commission such amendments and supplements to such Exchange Offer Registration Statement and the prospectus included therein as may
be necessary to effect and maintain the effectiveness of such Exchange Offer Registration Statement for the periods and purposes contemplated
in Section 2(a) hereof and as may be required by the applicable rules and regulations of the Commission and the instructions applicable
to the form of such Exchange Offer Registration Statement, and promptly provide each broker-dealer holding Exchange Notes with such number
of copies of the prospectus included therein (as then amended or supplemented), in conformity in all material respects with the requirements
of the Securities Act and the Trust Indenture Act, as such broker-dealer reasonably may request prior to the expiration of the Resale
Period, for use in connection with resales of Exchange Notes;

 

(iii)        prepare and furnish to each such holder
a reasonable number of copies of a prospectus supplemented or amended so that, as thereafter delivered to purchasers of such Exchange
Notes during the Resale Period, such prospectus conforms in all material respects to the applicable requirements of the Securities Act
and the Trust Indenture Act and shall not contain an untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing;

 

(iv)       
use their reasonable best efforts to obtain the withdrawal of any order suspending the effectiveness of such Exchange Offer Registration
Statement or any post-effective amendment thereto as soon as practicable;

 

(v)        
use their reasonable best efforts to (A) register or qualify the Exchange Notes under the securities laws or blue sky laws of such jurisdictions
as are contemplated by Section 2(a) no later than the commencement of the Exchange Offer, (B) keep such registrations or qualifications
in effect and comply with such laws so as to permit the continuance of offers, sales and dealings therein in such jurisdictions until
the expiration of the Resale Period and (C) take any and all other actions as may be reasonably necessary or advisable to enable each
broker-dealer holding Exchange Notes to consummate the disposition thereof in such jurisdictions; provided, however, that
neither of the Issuers shall be required for any such purpose to (1) qualify as a foreign corporation or limited liability company, as
the case may be, in any jurisdiction wherein it would not otherwise be required to qualify but for the requirements of this Section 3(c)(v),
(2) consent to general service of process in any such jurisdiction or (3) make any changes to its certificate of incorporation or by-laws
(or other organizational document) or any agreement between it and holders of its ownership interests;

 

    -9-

     

    

 

(vi)       
 use their reasonable best efforts to obtain the consent or approval of each governmental agency or authority, whether federal, state
or local, which may be required to effect the Exchange Offer Registration, the Exchange Offer and the offering and sale of Exchange Notes
by broker-dealers during the Resale Period;

 

(vii)       provide a CUSIP number for all Exchange Notes,
not later than the applicable Effective Time;

 

(viii)      comply with all applicable rules and
regulations of the Commission, and make generally available to their securityholders as soon as practicable but no later than eighteen
months after the effective date of such Exchange Offer Registration Statement, an earnings statement of the Company and its subsidiaries
complying with Section 11(a) of the Securities Act (including, at the option of the Company, Rule 158 thereunder);

 

(ix)       
mail to each holder a copy of the prospectus forming part of the Exchange Offer Registration Statement, together with an appropriate
letter of instruction and related documents;

 

(x)         utilize the services of a depositary for the
Exchange Offer, which may be the Trustee, any new trustee under the Indenture, or an affiliate of any of them;

 

(xi)       
permit holders to withdraw tendered Notes at any time prior to the close of business, New York time, on the last business day on which
the Exchange Offer is open;

 

(xii)      
prior to the Effective Time, provide a supplemental letter to the Commission (i) stating that the Issuers are conducting the Exchange
Offer in reliance on the position of the Commission in Exxon Capital Holdings Corporation (pub. avail. May 13, 1988), Morgan Stanley
and Co., Inc. (pub. avail. June 5, 1991); and (ii) including a representation that the Issuers have not entered into any arrangement
or understanding with any person to distribute the Exchange Notes to be received in the Exchange Offer and that, to the best of the Issuers’
information and belief, each holder participating in the Exchange Offer is acquiring the Exchange Notes in the ordinary course of business
and has no arrangement or understanding with any person to participate in the distribution of the Exchange Notes; and

 

(xiii)      provide the Representative, in advance
of filing thereof with the Commission, a draft of such Exchange Offer Registration Statement substantially in the form to be filed with
the Commission, each prospectus included therein or filed with the Commission and each amendment or supplement thereto (including any
documents incorporated by reference therein after the initial filing), and shall use their commercially reasonable efforts to reflect
in each such document, when so filed with the Commission, such comments as are reasonably proposed.

 

    -10-

     

    

 

(d)              
 As soon as practicable after the close of the Exchange Offer, the Issuers shall:

 

(i)          accept for exchange all Registrable Securities
tendered and not validly withdrawn pursuant to the Exchange Offer;

 

(ii)        
deliver to the Trustee for cancellation all Notes so accepted for exchange; and

 

(iii)       
cause the Trustee promptly to authenticate and deliver to each holder a principal amount of Exchange Notes equal to the principal amount
of the Registrable Securities of such Holder so accepted for exchange.

 

(e)              
In connection with the Issuers’ obligations with respect to the Shelf Registration, if applicable, the Issuers shall, as
soon as practicable (or as otherwise specified):

 

(i)          prepare and file with the Commission within
the time periods specified in Section 2(b), a Shelf Registration Statement on any form which may be utilized by the Issuers and which
shall register all the Registrable Securities for resale by the holders thereof in accordance with such method or methods of disposition
as may be specified by such of the holders as, from time to time, may be Electing Holders and use their reasonable best efforts to cause
such Shelf Registration Statement to become or be declared effective within the time periods specified in Section 2(b);

 

(ii)         not less than 30 calendar days prior to the
Effective Time of the Shelf Registration Statement, mail the Notice and Questionnaire to the holders of Registrable Securities; no holder
shall be entitled to be named as a selling securityholder in the Shelf Registration Statement as of the Effective Time, and no holder
shall be entitled to use the prospectus forming a part thereof for resales of Registrable Securities at any time, unless such holder has
returned a completed and signed Notice and Questionnaire to the Issuers by the deadline for response set forth therein; provided,
however, that holders of Registrable Securities shall have at least 28 calendar days from the date on which the Notice and Questionnaire
is first mailed to such holders to return a completed and signed Notice and Questionnaire to the Issuers;

 

(iii)        after the Effective Time of the Shelf
Registration Statement, upon the request of any holder of Registrable Securities that is not then an Electing Holder, promptly send a
Notice and Questionnaire to such holder; provided that the Issuers shall not be required to take any action to name such holder
as a selling securityholder in the Shelf Registration Statement or to enable such holder to use the prospectus forming a part thereof
for resales of Registrable Securities until such holder has returned a completed and signed Notice and Questionnaire to the Issuers;

 

    -11-

     

    

 

(iv)       
 as soon as practicable prepare and file with the Commission such amendments and supplements to such Shelf Registration Statement and
the prospectus included therein as may be necessary to effect and maintain the effectiveness of such Shelf Registration Statement for
the period specified in Section 2(b) and as may be required by the applicable rules and regulations of the Commission and the instructions
applicable to the form of such Shelf Registration Statement, and furnish to the Electing Holders copies of any such supplement or amendment
simultaneously with or prior to its being used or filed with the Commission;

 

(v)         comply with the provisions of the Securities
Act with respect to the disposition of all the Registrable Securities covered by such Shelf Registration Statement in accordance with
the intended methods of disposition by the Electing Holders provided for in such Shelf Registration Statement;

 

(vi)        provide (A) the Electing Holders, (B)
the underwriters (which term, for purposes of this Agreement, shall include a person deemed to be an underwriter within the meaning of
Section 2(a)(11) of the Securities Act), if any, thereof, (C) any sales or placement agent therefor, (D) counsel for any such underwriter
or agent, (E) not more than one counsel for all the Electing Holders and (F) the Representative, in advance of filing thereof with the
Commission, a draft of such Shelf Registration Statement, each prospectus included therein or filed with the Commission and each amendment
or supplement thereto (including any documents incorporated by reference therein after the initial filing), in each case in substantially
the form to be filed with the Commission, and shall use their commercially reasonable efforts to reflect in each such document, when so
filed with the Commission, such comments as are reasonably proposed;

 

(vii)      for a reasonable period prior to the
filing of such Shelf Registration Statement, and throughout the period specified in Section 2(b), make available at reasonable times
at each Issuer’s principal place of business, or such other reasonable place for inspection by the persons referred to in
Section 3(e)(vi) who shall certify to the Issuers that they have a current intention to sell the Registrable Securities pursuant to
the Shelf Registration, such financial and other relevant information and books and records of the Issuers, each of their
subsidiaries and, as relevant, Parent Companies, and cause each of their officers, employees, counsel and independent certified
public accountants to supply all relevant information and to respond to such inquiries, as shall be reasonably necessary, in the
judgment of the respective counsel referred to in such Section, to conduct a reasonable investigation within the meaning of Section
11 of the Securities Act; provided, however, that each such party shall be required to maintain in confidence and not
to disclose to any other person any information or records reasonably designated by the Issuers as being confidential, until such
time as (A) such information becomes a matter of public record (whether by virtue of its inclusion in such registration statement or
otherwise, except as a result of a breach of this or any other obligation of confidentiality to the Issuers), or (B) such person
shall be required so to disclose such information pursuant to a subpoena or order of any court or other governmental agency or body
having jurisdiction over the matter (subject to the requirements of such order, and only after such person shall have given the
Issuers prompt prior written notice of such requirement), or (C) such information is required to be set forth in such Shelf
Registration Statement or the prospectus included therein or in an amendment to such Shelf Registration Statement or an amendment or
supplement to such prospectus in order that such Shelf Registration Statement, prospectus, amendment or supplement, as the case may
be, complies with applicable requirements of the federal securities laws and the rules and regulations of the Commission and does
not contain an untrue statement of a material fact or omit to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading in light of the circumstances then existing, provided further, however,
that notwithstanding anything to the contrary in this clause (vii), any such person (and each employee, representative, or other
agent of such person) may disclose to any and all persons, without limitation, the U.S. tax treatment and any facts that may be
relevant to the tax structure of the matters covered by and relating to this Agreement (including opinions or other tax analysis
that are provided to such party relating to such tax treatment and tax structure); provided, however, that no person
(and no employee, representative, or other agent of any person) shall disclose any other information that is not relevant to
understanding the tax treatment and tax structure of the matters covered by and relating to this Agreement (including the identity
of any party and any information that could lead another to determine the identity of any party), or any other information to the
extent that such non-disclosure is reasonably necessary in order to comply with applicable securities law;

 

    -12-

     

    

 

(viii)     
promptly notify each of the Representative, the Electing Holders, any sales or placement agent therefor and any underwriter thereof (which
notification may be made through any managing underwriter that is a representative of such underwriter for such purpose) and confirm
such advice in writing, (A) when such Shelf Registration Statement or the prospectus included therein or any prospectus amendment or
supplement or post-effective amendment has been filed, and, with respect to such Shelf Registration Statement or any post-effective amendment,
when the same has become effective, (B) of any comments by the Commission and by the blue sky or securities commissioner or regulator
of any state with respect thereto, or any request by the Commission for amendments or supplements to such Shelf Registration Statement
or prospectus or for additional information, (C) of the issuance by the Commission of any stop order suspending the effectiveness of
such Shelf Registration Statement or the initiation or, to the knowledge of the Issuers, threatening of any proceedings for that purpose,
(D) if at any time the representations and warranties of the Issuers contemplated by Section 3(e)(xvii) or Section 5 hereof cease to
be true and correct in all material respects, (E) of the receipt by the Issuers of any notification with respect to the suspension of
the qualification of the Registrable Securities for sale in any jurisdiction or the initiation or, to the knowledge of the Issuers, threatening
of any proceeding for such purpose, or (F) if at any time when a prospectus is required to be delivered under the Securities Act, that
such Shelf Registration Statement, prospectus, prospectus amendment or supplement or post-effective amendment does not conform in all
material respects to the applicable requirements of the Securities Act and the Trust Indenture Act, or contains an untrue statement of
a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading
in light of the circumstances then existing;

 

    -13-

     

    

 

  

(ix)             use their reasonable best efforts to obtain
the withdrawal of any order suspending the effectiveness of such Shelf Registration Statement or any post-effective amendment thereto
as soon as practicable;

 

(x)              if requested by any managing underwriter or underwriters,
any placement or sales agent or any Electing Holder, promptly incorporate in a prospectus supplement or post-effective amendment such
information as is required by the applicable rules and regulations of the Commission, and as such managing underwriter or underwriters,
such agent or such Electing Holder specifies should be included therein relating to the terms of the sale of such Registrable Securities,
including, without limitation, information (i) with respect to the principal amount of Registrable Securities being sold by such Electing
Holder or agent or to any underwriters, the name and description of such Electing Holder, agent or underwriter, the offering price of
such Registrable Securities, and any discount, commission or other compensation payable in respect thereof and the purchase price being
paid therefor by such underwriters and (ii) with respect to any other material terms of the offering of the Registrable Securities to
be sold by such Electing Holder or agent or to such underwriters; and make all required filings of such prospectus supplement or post-effective
amendment upon notification of the matters to be incorporated in such prospectus supplement or post-effective amendment;

 

(xi)             furnish to each Electing Holder,
each placement or sales agent, if any, therefor, each underwriter, if any, thereof and the respective counsel referred to in Section
3(e)(vi) hereof an executed copy (or, in the case of an Electing Holder, a conformed copy) of such Shelf Registration Statement,
each such amendment and supplement thereto (in each case including all exhibits thereto (in the case of an Electing Holder of
Registrable Securities, upon request) and documents incorporated by reference therein) and such number of copies of such Shelf
Registration Statement (excluding exhibits thereto and documents incorporated by reference therein unless specifically so requested
by such Electing Holder, agent or underwriter, as the case may be) and of the prospectus included in such Shelf Registration
Statement (including, without limitation, each preliminary prospectus and any summary prospectus), in conformity in all material
respects with the applicable requirements of the Securities Act and the Trust Indenture Act, and such other documents, as such
Electing Holder, agent, if any, and underwriter, if any, may reasonably request in order to facilitate the offering and disposition
of the Registrable Securities owned by such Electing Holder, offered or sold by such agent or underwritten by such underwriter and
to permit such Electing Holder, agent and underwriter to satisfy the prospectus delivery requirements of the Securities Act; and the
Issuers hereby consent to the use of such prospectus (including, without limitation, such preliminary and summary prospectus) and
any amendment or supplement thereto by each such Electing Holder and by any such agent and underwriter, in each case in the form
most recently provided to such person by the Issuers, in connection with the offering and sale of the Registrable Securities covered
by the prospectus (including, without limitation, such preliminary and summary prospectus) or any supplement or amendment
thereto;

 

    -14-

     

    

 

(xii)            use their reasonable best efforts to (A) register
or qualify the Registrable Securities to be included in such Shelf Registration Statement under such securities laws or blue sky laws
of such jurisdictions as any Electing Holder and each placement or sales agent, if any, therefor and underwriter, if any, thereof shall
reasonably request, (B) keep such registrations or qualifications in effect and comply with such laws so as to permit the continuance
of offers, sales and dealings therein in such jurisdictions during the period the Shelf Registration is required to remain effective
under Section 2(b) above and for so long as may be necessary to enable any such Electing Holder, agent or underwriter to complete its
distribution of the Registrable Securities pursuant to such Shelf Registration Statement and (C) take any and all other actions as may
be reasonably necessary or advisable to enable each such Electing Holder, agent, if any, and underwriter, if any, to consummate the disposition
in such jurisdictions of such Registrable Securities; provided, however, that neither of the Issuers shall be required
for any such purpose to (1) qualify as a foreign corporation or limited liability company, as the case may be, in any jurisdiction wherein
it would not otherwise be required to qualify but for the requirements of this Section 3(d)(xii), (2) consent to general service of process
in any such jurisdiction or (3) make any changes to its certificate of incorporation or by-laws (or other organizational document) or
any agreement between it and holders of its ownership interests;

 

(xiii)            use
their reasonable best efforts to obtain the consent or approval of each governmental agency or authority, whether federal, state or local,
which may be required to effect the Shelf Registration or the offering or sale in connection therewith or to enable the selling holder
or holders to offer, or to consummate the disposition of, their Registrable Securities;

 

(xiv)           unless
any Registrable Securities shall be in book-entry only form, cooperate with the Electing Holders and the managing underwriters, if any,
to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold, which certificates,
if so required by any securities exchange upon which any Registrable Securities are listed, shall be penned, lithographed or engraved,
or produced by any combination of such methods, on steel engraved borders, and which certificates shall not bear any restrictive legends;
and, in the case of an underwritten offering, enable such Registrable Securities to be in such denominations and registered in such names
as the managing underwriters may request at least two business days prior to any sale of the Registrable Securities;

 

    -15-

     

    

 

(xv)          
 provide a CUSIP number for all Registrable Securities, not later than the applicable Effective Time;

 

(xvi)          enter
into one or more underwriting agreements, engagement letters, agency agreements, “best efforts” underwriting agreements or
similar agreements, as appropriate, including customary provisions relating to indemnification and contribution (but no less favorable
than those set forth in Section 6 with respect to all parties indemnified under Section 6), unless such provisions are acceptable to
Electing Holders of at least 50% in aggregate principal amount of the Registrable Securities and any managing underwriters, and take
such other actions in connection therewith as any Electing Holders of at least 20% in aggregate principal amount of the Registrable Securities
at the time outstanding shall request in order to expedite or facilitate the disposition of such Registrable Securities;

 

(xvii)         whether
or not an agreement of the type referred to in Section 3(e)(xvi) hereof is entered into, and whether or not any portion of the offering
contemplated by the Shelf Registration is an underwritten offering or is made through a placement or sales agent or any other entity,
(A) make such representations and warranties to the Electing Holders and the placement or sales agent, if any, therefor and the underwriters,
if any, thereof in form, substance and scope as are customarily made in connection with an offering of debt securities pursuant to any
appropriate agreement or to a registration statement filed on the form applicable to the Shelf Registration; (B) obtain an opinion of
counsel to the Issuers in customary form, subject to customary limitations, assumptions and exclusions, and covering such matters, of
the type customarily covered by such an opinion, as the managing underwriters, if any, or as any Electing Holders of at least 20% in
aggregate principal amount of the Registrable Securities at the time outstanding may reasonably request, addressed to such Electing Holder
or Electing Holders and the placement or sales agent, if any, therefor and the underwriters, if any, thereof and dated the date of the
Effective Time of such Shelf Registration Statement (and if such Shelf Registration Statement contemplates an underwritten offering of
a part or all of the Registrable Securities, dated the date of the closing under the underwriting agreement relating thereto) (it being
agreed that the matters to be covered by such opinion shall include the matters set forth in paragraphs (b) and (c) of Section 8 of the
Purchase Agreement to the extent applicable to an offering of this type); (C) obtain a “cold comfort” letter or letters from
the independent certified public accountants of the Issuers addressed to the selling Electing Holders, the placement or sales agent,
if any, therefor or the underwriters, if any, thereof, dated (i) the effective date of such Shelf Registration Statement and (ii) the
effective date of any prospectus supplement to the prospectus included in such Shelf Registration Statement or post-effective amendment
to such Shelf Registration Statement which includes unaudited or audited financial statements as of a date or for a period subsequent
to that of the latest such statements included in such prospectus (and, if such Shelf Registration Statement contemplates an underwritten
offering pursuant to any prospectus supplement to the prospectus included in such Shelf Registration Statement or post-effective amendment
to such Shelf Registration Statement which includes unaudited or audited financial statements as of a date or for a period subsequent
to that of the latest such statements included in such prospectus, dated the date of the closing under the underwriting agreement relating
thereto), such letter or letters to be in customary form and covering such matters of the type customarily covered by letters of such
type; (D) deliver such documents and certificates, including, without limitation, officers’ certificates, as may be reasonably
requested by any Electing Holders of at least 20% in aggregate principal amount of the Registrable Securities at the time outstanding
or the placement or sales agent, if any, therefor and the managing underwriters, if any, thereof to evidence the accuracy of the representations
and warranties made pursuant to clause (A) above or those contained in Section 5(a) hereof and the compliance with or satisfaction of
any agreements or conditions contained in the underwriting agreement or other similar agreement entered into by the Issuers pursuant
to Section 3(e)(xvi); and (E) undertake such obligations relating to expense reimbursement, indemnification and contribution as are provided
in Section 6 hereof;

 

    -16-

     

    

 

(xviii)        notify
in writing each holder of Registrable Securities of any proposal by the Issuers to amend or waive any provision of this Agreement pursuant
to Section 9(h) hereof and of any amendment or waiver effected pursuant thereto, each of which notices shall contain the substance of
the amendment or waiver proposed or effected, as the case may be;

 

 (xix)          
in the event that any broker-dealer registered under the Exchange Act shall underwrite any Registrable Securities or participate as a
member of an underwriting syndicate or selling group or “assist in the distribution” (within the meaning of the Conduct Rules
(the “Conduct Rules”) of the Financial Industry Regulatory Authority, Inc. (“FINRA”) or any successor
thereto, as amended from time to time) thereof, whether as a holder of such Registrable Securities or as an underwriter, a placement
or sales agent or a broker or dealer in respect thereof, or otherwise, assist such broker-dealer in complying with the requirements of
such Conduct Rules, including, without limitation, by (A) if such Conduct Rules shall so require, engaging a “qualified independent
underwriter” (as defined in such Conduct Rules) to participate in the preparation of the Shelf Registration Statement relating
to such Registrable Securities, to exercise usual standards of due diligence in respect thereto and, if any portion of the offering contemplated
by such Shelf Registration Statement is an underwritten offering or is made through a placement or sales agent, to recommend the yield
of such Registrable Securities, (B) indemnifying any such qualified independent underwriter to the extent of the indemnification of underwriters
provided in Section 6 hereof (or to such other customary extent as may be requested by such underwriter), and (C) providing such information
to such broker-dealer as may be required in order for such broker-dealer to comply with the requirements of the Conduct Rules; and

 

(xx)             comply
with all applicable rules and regulations of the Commission, and make generally available to its securityholders as soon as practicable
but in any event not later than eighteen months after the effective date of such Shelf Registration Statement, an earnings statement
of the Company and its subsidiaries complying with Section 11(a) of the Securities Act (including, at the option of the Company, Rule
158 thereunder).

 

    -17-

     

    

 

(f)               
In the event that the Issuers would be required, pursuant to Section 3(e)(viii)(F) hereof, to notify the Electing Holders, the
placement or sales agent, if any, therefor and the managing underwriters, if any, thereof, the Issuers shall prepare and furnish to each
of the Electing Holders, to each placement or sales agent, if any, and to each such underwriter, if any, a reasonable number of copies
of a prospectus supplemented or amended so that, as thereafter delivered to purchasers of Registrable Securities, such prospectus conforms
in all material respects to the applicable requirements of the Securities Act and the Trust Indenture Act, and shall not contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein
not misleading in light of the circumstances then existing. Each Electing Holder agrees that upon receipt of any notice from the Issuers
pursuant to Section 3(e)(viii)(F) hereof, such Electing Holder shall forthwith discontinue the disposition of Registrable Securities pursuant
to the Shelf Registration Statement applicable to such Registrable Securities until such Electing Holder shall have received copies of
such amended or supplemented prospectus, and if so directed by the Issuers, such Electing Holder shall deliver to the Issuers (at the
Issuers’ expense) all copies, other than permanent file copies, then in such Electing Holder’s possession of the prospectus
covering such Registrable Securities at the time of receipt of such notice.

 

(g)              
In the event of a Shelf Registration, in addition to the information required to be provided by each Electing Holder in its Notice
and Questionnaire, the Issuers may require such Electing Holder to furnish to the Issuers such additional information regarding such Electing
Holder and such Electing Holder’s intended method of distribution of Registrable Securities as may be required in order to comply
with the Securities Act. Each such Electing Holder agrees to notify the Issuers as promptly as practicable of any inaccuracy or change
in information previously furnished by such Electing Holder to the Issuers or of the occurrence of any event in either case as a result
of which any prospectus relating to such Shelf Registration contains or would contain an untrue statement of a material fact regarding
such Electing Holder or such Electing Holder’s intended method of disposition of such Registrable Securities or omits to state any
material fact regarding such Electing Holder or such Electing Holder’s intended method of disposition of such Registrable Securities
required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing,
and promptly to furnish to the Issuers any additional information required to correct and update any previously furnished information
or required so that such prospectus shall not contain, with respect to such Electing Holder or the disposition of such Registrable Securities,
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading in light of the circumstances then existing.

 

    -18-

     

    

 

SECTION 4.           Registration
Expenses. The Issuers agree, subject to the last sentence of this Section 4, to bear and to pay or cause to be paid promptly all
expenses incident to the Issuers’ performance of or compliance with this Agreement, including, without limitation, (a) all Commission
and any FINRA registration, filing and review fees and expenses including, without limitation, fees and disbursements of counsel for
the placement or sales agent or underwriters in connection with such registration, filing and review, (b) all fees and expenses in connection
with the qualification of the Notes for offering and sale under the securities laws and blue sky laws referred to in Section 3(e)(xii)
hereof and determination of their eligibility for investment under the laws of such jurisdictions as any managing underwriters or the
Electing Holders may designate, including, without limitation, any fees and disbursements of counsel for the Electing Holders or underwriters
in connection with such qualification and determination, (c) all expenses relating to the preparation, printing, production, distribution
and reproduction of each registration statement required to be filed hereunder, each prospectus included therein or prepared for distribution
pursuant hereto, each amendment or supplement to the foregoing, the expenses of preparing the Notes for delivery and the expenses of
printing or producing any underwriting agreements, agreements among underwriters, selling agreements and blue sky or legal investment
memoranda and all other documents in connection with the offering, sale or delivery of Notes to be disposed of (including, without limitation,
certificates representing the Notes), (d) messenger, telephone and delivery expenses relating to the offering, sale or delivery of Notes
and the preparation of documents referred in clause (c) above, (e) fees and expenses of the Trustee under the Indenture, any agent of
the Trustee and any reasonable fees and expenses for counsel for the Trustee and of any collateral agent or custodian, (f) internal expenses
(including, without limitation, all salaries and expenses of each Issuer’s officers and employees performing legal or accounting
duties), (g) fees, disbursements and expenses of counsel and independent certified public accountants of the Issuers (including, without
limitation, the expenses of any opinions or “cold comfort” letters required by or incidental to such performance and compliance),
(h) reasonable fees, disbursements and expenses of one counsel for the Electing Holders retained in connection with a Shelf Registration,
as selected by the Electing Holders of at least a majority in aggregate principal amount of the Registrable Securities held by Electing
Holders (which counsel shall be reasonably satisfactory to the Issuers), (i) any fees charged by securities rating services engaged by
the Issuers for rating the Notes, and (j) reasonable fees, expenses and disbursements of any other persons, including, without limitation,
special experts, retained by the Issuers in connection with such registration (collectively, the “Registration Expenses”).
To the extent that any Registration Expenses are incurred, assumed or paid by any holder of Registrable Securities or any placement or
sales agent therefor or underwriter thereof, the Issuers shall reimburse such person for the full amount of the Registration Expenses
so incurred, assumed or paid promptly after receipt of a request therefor. Notwithstanding the foregoing, the holders of the Registrable
Securities being registered shall pay all agency fees and commissions and underwriting discounts and commissions attributable to the
sale of such Registrable Securities and the fees and disbursements of any counsel or other advisors or experts retained by such holders
(severally or jointly), other than the counsel and experts specifically referred to above.

 

SECTION
5.           Representations, Warranties and Covenants. Except with respect
to clauses (a) and (b) below, the Issuers represent and warrant to, and agree with, each Purchaser and each of the holders from time to
time of Registrable Securities the information set forth in this Section 5.

 

    -19-

     

    

 

With respect to clauses (a) and (b) below, the Issuers
covenant that:

 

(a)              
Each registration statement covering Registrable Securities and each prospectus (including, without limitation, any preliminary
or summary prospectus) contained therein or furnished pursuant to Section 3(e) or Section 3(c) hereof and any further amendments or supplements
to any such registration statement or prospectus, when it becomes effective or is filed with the Commission, as the case may be, and,
in the case of an underwritten offering of Registrable Securities, at the time of the closing under the underwriting agreement relating
thereto, will conform in all material respects to the requirements of the Securities Act and the Trust Indenture Act and will not contain
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading; and at all times subsequent to the Effective Time when a prospectus would be required to be delivered under the
Securities Act, other than from (i) such time as a notice has been given to holders of Registrable Securities pursuant to Section 3(e)(viii)(F)
or Section 3(c)(iii) hereof until (ii) such time as the Issuers furnish an amended or supplemented prospectus pursuant to Section 3(f)
or Section 3(c)(iii) hereof, each such registration statement, and each prospectus (including, without limitation, any preliminary or
summary prospectus) contained therein or furnished pursuant to Section 3(e) or Section 3(c) hereof, as then amended or supplemented, will
conform in all material respects to the requirements of the Securities Act and the Trust Indenture Act and will not contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein
not misleading in the light of the circumstances then existing; provided, however, that this covenant shall not apply to
any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Issuers by a holder of
Registrable Securities expressly for use therein.

 

(b)              
Any documents incorporated by reference in any prospectus referred to in Section 5(a) hereof, when they become or became effective
or are or were filed with the Commission, as the case may be, will conform or conformed in all material respects to the requirements of
the Securities Act or the Exchange Act, as applicable, and none of such documents will contain or contained an untrue statement of a material
fact or will omit or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading;
provided, however, that this covenant shall not apply to any statements or omissions made in reliance upon and in conformity
with information furnished in writing to the Issuers by a holder of Registrable Securities expressly for use therein.

 

(c)              
This Agreement has been duly authorized, executed and delivered by the Issuers.

 

    -20-

     

    

 

SECTION
6.           Indemnification.

 

(a)               The
Issuers, jointly and severally, agree to indemnify and hold harmless each holder of Registrable Securities or Exchange Notes, as the
case may be, covered by any Exchange Offer Registration Statement or Shelf Registration Statement (including each Purchaser and,
with respect to any prospectus delivery as contemplated in Section 3(c)(ii) or (iii) hereof, each holder (which may include any
Purchaser) that is a broker-dealer and elects to exchange for Exchange Notes any Registrable Securities that it acquired for its own
account as a result of market-making activities or other trading activities (but not directly from the Issuers or any affiliate of
the Issuers) for Exchange Notes) (each an “Exchanging Dealer”), the affiliates, directors, officers, employees
and agents of each such holder and each person who controls any such holder within the meaning of either the Securities Act or the
Exchange Act against any and all losses, claims, damages or liabilities, joint or several, to which they or any of them may become
subject under the Securities Act, the Exchange Act or other Federal or state statutory law or regulation, at common law or
otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any
untrue statement or alleged untrue statement of a material fact contained in the Exchange Offer Registration Statement or Shelf
Registration Statement as originally filed or in any amendment thereof, or in any preliminary prospectus or the prospectus included
in any registration statement, or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or
alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not
misleading, and agrees to reimburse each such indemnified party, as incurred, for any legal or other expenses reasonably incurred by
them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however,
that the Issuers will not be liable in any case to the extent that any such loss, claim, damage or liability arises out of or is
based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and
in conformity with written information furnished to the Issuers by or on behalf of any such holder specifically for inclusion
therein. This indemnity agreement will be in addition to any liability which the Issuers may otherwise have.

 

The Issuers, jointly and severally, also agree to
indemnify or contribute as provided in Section 6(d) to Losses of any underwriter of Registrable Securities or Exchange Notes, as the case
may be, registered under a Shelf Registration Statement, their directors, officers, employees or agents and each person who controls such
underwriter within the meaning of either the Securities Act or the Exchange Act, on substantially the same basis as that of the indemnification
of the Purchasers and the selling holders provided in this Section 6(a) and shall, if requested by any holder, enter into an underwriting
agreement reflecting such agreement, as provided in Section 3(e)(xvi) hereof.

 

(b)              
Each holder of Registrable Securities or Exchange Notes covered by an Exchange Offer Registration Statement or Shelf Registration
Statement (including each Purchaser and, with respect to any prospectus delivery as contemplated in Section 3(c)(ii) or Section 3(f)(iv)
hereof, each Exchanging Dealer) severally agrees to indemnify and hold harmless the Issuers, and each of their affiliates, directors,
employees, members, managers and agents and each Person who controls the Issuers within the meaning of either the Securities Act or the
Exchange Act, to the same extent as the foregoing indemnity from the Issuers to each such holder, but only with reference to written information
relating to such holder furnished to the Issuers by or on behalf of such holder specifically for inclusion in the documents referred to
in the foregoing indemnity. This indemnity agreement will be in addition to any liability which any such holder may otherwise have.

 

    -21-

     

    

 

(c)              
 Promptly after receipt by an indemnified party under this Section 6 or notice of the commencement of any action, such indemnified
party will, if a claim in respect thereof is to be made against the indemnifying party under this Section 6, notify the indemnifying party
in writing of the commencement thereof; but the failure so to notify the indemnifying party (i) will not relieve it from liability under
paragraph (a) or (b) above unless and to the extent such action and such failure results in the forfeiture by the indemnifying party of
substantial rights and defenses; and (ii) will not, in any event, relieve the indemnifying party from any obligations to any indemnified
party other than the indemnification obligation provided in paragraph (a) or (b) above. The indemnifying party shall be entitled to participate
therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof,
with counsel satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party, be counsel to the
indemnifying party), and, except as provided in the next sentence, after notice from the indemnifying party to such indemnified party
of its election to so assume the defense thereof, the indemnifying party shall not be liable to such indemnified party for any legal expenses
of other counsel or any other expenses, in each case subsequently incurred by such indemnified party, in connection with the defense thereof
other than reasonable costs of investigation. Notwithstanding the indemnifying party’s rights in the prior sentence, the indemnified
party shall have the right to employ its own counsel (and one local counsel), and the indemnifying party shall bear the reasonable fees,
costs and expenses of such separate counsel if (i) the use of counsel chosen by the indemnifying party to represent the indemnified party
would present such counsel with a conflict of interest; (ii) the actual or potential defendants in, or targets of, any such action include
both the indemnified party and the indemnifying party and the indemnified party shall have reasonably concluded that there may be legal
defenses available to it and/or other indemnified parties which are different from or additional to those available to the indemnifying
party; (iii) the indemnifying party shall not have employed counsel satisfactory to the indemnified party to represent the indemnified
party within a reasonable time after notice of the institution of such action; or (iv) the indemnifying party shall authorize the indemnified
party to employ separate counsel at the expense of the indemnifying party. No indemnifying party shall, in connection with any one action
or separate but substantially similar or related actions in the same jurisdiction arising out of the same general circumstances or allegations,
be liable for the fees and expenses of more than one separate firm of attorneys (in addition to any local counsel) for all indemnified
parties. An indemnifying party shall not be liable under this Section 6 to any indemnified party regarding any settlement or compromise
or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which
indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such
claim or action) unless such settlement, compromise or consent is consented to by such indemnifying party, which consent shall not be
unreasonably withheld.

 

    -22-

     

    

 

(d)               In
the event that the indemnity provided in paragraph (a) or (b) of this Section 6 is unavailable to or insufficient to hold harmless
an indemnified party for any reason, then each applicable indemnifying party agrees to contribute to the aggregate losses, claims,
damages and liabilities (including, without limitation, legal or other expenses reasonably incurred in connection with investigating
or defending same) (collectively “Losses”) to which such indemnifying party may be subject in such proportion as
is appropriate to reflect the relative benefits received by the indemnifying party on the one hand and by the indemnified party on
the other from the offering of the Notes. If, however, the allocation provided by the immediately preceding sentence is not
permitted by applicable law or if the indemnified party failed to give the notice required under subsection (c) above, then each
indemnifying party shall contribute to such amount paid or payable by such indemnified party in such proportion as is appropriate to
reflect not only such relative benefits but also the relative fault of the indemnifying party on the one hand and the indemnified
party on the other in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or
actions in respect thereof), as well as any other relevant equitable considerations. Benefits received by the Issuers shall be
deemed to be equal to the sum of (x) the total net proceeds from the initial placement of the Notes (before deducting expenses)
reflected in the Purchase Agreement and (y) the total amount of Special Interest which the Issuers were not required to pay as a
result of registering the securities covered by the Exchange Offer Registration Statement or Shelf Registration Statement which
resulted in such Losses. Benefits received by the Purchasers shall be deemed to be equal to the total purchase discounts and
commissions as reflected in the Purchase Agreement, and benefits received by any other holders shall be deemed to be equal to the
proceeds received from the sale of the Registrable Securities or Exchange Notes, as applicable. Benefits received by any underwriter
shall be deemed to be equal to the total underwriting discounts and commissions, as set forth in the prospectus forming a part of
the Exchange Offer Registration Statement or Shelf Registration Statement which resulted in such Losses. The relative fault shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the indemnifying party on the one hand or the
indemnified party on the other and the parties’ relative intent, knowledge, access to information and opportunity to correct
or prevent such statement or omission. The parties agree that it would not be just and equitable if contribution pursuant to this
subsection (d) were determined by pro rata allocation (even if the holders or any agents or underwriters or all of them were treated
as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations
referred to above in this subsection (d). The amount paid or payable by an indemnified party as a result of the losses, claims,
damages or liabilities (or actions in respect thereof) referred to above in this subsection (d) shall be deemed to include any legal
or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or
claim. Notwithstanding the provisions of this subsection (d), no holder shall be required to contribute any amount in excess of the
amount by which the dollar amount of the proceeds received by such holder from the sale of Registrable Securities (after deducting
any fees, discounts and commissions applicable thereto) exceeds the amount of any damages which such holder has otherwise been
required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission, and no underwriter shall be
required to contribute any amount in excess of the amount by which the total price of the Registrable Securities underwritten by it
and distributed to the public exceeds the amount of any damages which such underwriter has otherwise been required to pay by reason
of such untrue or alleged untrue statement or omission or alleged omission. The holders’ and any underwriters’
obligations in this subsection (d) to contribute are several in proportion to the principal amount of Registrable Securities
registered or underwritten, as the case may be, by them, and not joint. Notwithstanding the provisions of this paragraph (d), no
person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 6, each person
who controls any holder, agent or underwriter within the meaning of either the Securities Act or the Exchange Act and each director,
officer, employee and agent of a holder, agent or underwriter shall have the same rights to contribution as such holder, agent or
underwriter, and each person who controls the Issuers within the meaning of either the Securities Act or the Exchange Act and each
officer and director of the Issuers shall have the same rights to contribution as the Issuers, subject in each case to the
applicable terms and conditions of this paragraph (d).

 

    -23-

     

    

 

(e)              
The provisions of this Section will remain in full force and effect, regardless of any investigation made by or on behalf of any
holder or the Issuers or any of the officers, directors or controlling persons referred to in this Section hereof, and will survive the
sale by a holder of securities covered by an Exchange Offer Registration Statement or Shelf Registration Statement.

 

SECTION
7.           Underwritten Offerings.

 

(a)              
Selection of Underwriters. If any of the Registrable Securities covered by the Shelf Registration are to be sold pursuant
to an underwritten offering, the managing underwriter or underwriters thereof shall be designated by Electing Holders holding at least
a majority in aggregate principal amount of the Registrable Securities to be included in such offering, provided that such designated
managing underwriter or underwriters is or are reasonably acceptable to the Issuers.

 

(b)              
Participation by Holders. Each holder of Registrable Securities hereby agrees with each other such holder that no such holder
may participate in any underwritten offering hereunder unless such holder (i) agrees to sell such holder’s Registrable Securities
on the basis provided in any underwriting arrangements with respect to such Registrable Securities approved by the persons entitled hereunder
to approve such arrangements and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements
and other documents reasonably required under the terms of such underwriting arrangements.

 

(c)              
Minimum Requirements. With respect to the Notes, the Issuers shall not have any obligations with respect to any underwriters
or underwritten offering except a single underwritten offering of $270 million or more of Registrable Securities.

 

SECTION
8.           Rule 144.

 

(a)              
Each of the Issuers covenants to the holders of Registrable Securities that to the extent it shall be required to do so under the
Exchange Act, it shall timely file the reports required to be filed by it under the Exchange Act or the Securities Act (including, without
limitation, the reports under Section 13 and 15(d) of the Exchange Act referred to in subparagraph (c)(1) of Rule 144), and shall take
such further action as any holder of Registrable Securities may reasonably request, all to the extent required from time to time to enable
such holder to sell Registrable Securities without registration under the Securities Act within the limitations of the exemption provided
by Rule 144, or any similar or successor rule or regulation hereafter adopted by the Commission. Upon the request of any holder of Registrable
Securities in connection with that holder’s sale pursuant to Rule 144, the Issuers shall deliver to such holder a written statement
as to whether they have complied with such requirements.

 

    -24-

     

    

 

 

(b)              
 At any time while any of the Notes are “restricted securities” within the meaning of Rule 144, if the Company is no
longer subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act (as opposed to just having the obligations suspended),
the Company or a Parent (as defined in the Indenture) shall prepare and furnish to any Holder, any beneficial owner of the Notes and any
prospective purchaser of Notes designated by a Holder or a beneficial owner of the Notes, promptly upon request, the information required
pursuant to Rule 144A(d)(4) (or any successor thereto) under the Securities Act in connection with the offer, sale or transfer of Notes.
Such information may be provided by a Parent in filings with the Commission which filing shall satisfy the obligations set forth in this
clause (b). The requirements set forth in this clause (b) will not be applicable after the one year anniversary of the issuance of any
Notes.

 

SECTION
9.           Miscellaneous.

 

(a)              
No Inconsistent Agreements. The Issuers represent, warrant, covenant and agree that they have not granted, and shall not
grant, registration rights with respect to Registrable Securities or any other Notes which would be inconsistent with the terms contained
in this Agreement.

 

(b)              
Specific Performance. Except with respect to a Registration Default, the parties hereto acknowledge that there would be
no adequate remedy at law if the Issuers fail to perform any of their obligations hereunder and that the Purchasers and the holders from
time to time of the Registrable Securities may be irreparably harmed by any such failure, and accordingly agree that the Purchasers and
such holders, in addition to any other remedy to which they may be entitled at law or in equity, shall be entitled to compel specific
performance of the obligations of the Issuers under this Agreement in accordance with the terms and conditions of this Agreement, in any
court of the United States or any State thereof having jurisdiction.

 

(c)              
Notices. All notices, requests, claims, demands, waivers and other communications hereunder shall be in writing and shall
be deemed to have been duly given (i) when delivered by hand, if delivered personally or by courier, (ii) when sent by facsimile (with
written confirmation of receipt), provided that a copy is mailed by registered or certified mail, return receipt requested or (iii)
three days after being deposited in the mail (registered or certified mail, postage prepaid, return receipt requested) as follows: if
to the Issuers, c/o CCO Holdings, LLC, 400 Washington Boulevard, Stamford, Connecticut 06902, Attention: General Counsel, Facsimile No.: (203)
564-1377 and if to a holder, to the address of such holder set forth in the security register or other records of the Issuers, or to such
other address as the Issuers or any such holder may have furnished to the other in writing in accordance herewith, with a copy in like
manner c/o Deutsche Bank Securities Inc. at 60 Wall Street, New York, New York 10005, Attention: Debt Capital Markets, with a copy to
the General Counsel, Facsimile No.: (646) 374-1071. Notices of change of address shall be effective only upon receipt.

 

(d)               Parties
in Interest. All the terms and provisions of this Agreement shall be binding upon, shall inure to the benefit of and shall be
enforceable by the parties hereto and the holders from time to time of the Registrable Securities and the respective successors and
assigns of the parties hereto and such holders. In the event that any person shall acquire Registrable Securities, in any manner,
whether by gift, bequest, purchase, operation of law or otherwise, such transferee shall, without any further writing or action of
any kind, be deemed a beneficiary hereof for all purposes and such Registrable Securities shall be held subject to all the terms of
this Agreement, and by taking and holding such Registrable Securities such transferee shall be entitled to receive the benefits, and
be conclusively deemed to have agreed to be bound by all the applicable terms and provisions, of this Agreement. If the Issuers
shall so request, any such successor, assign or transferee shall agree in writing to acquire and hold the Registrable Securities
subject to all the applicable terms hereof.

 

    -25-

     

    

 

(e)              
Survival. The respective indemnities, agreements, representations, warranties and each other provision set forth in this
Agreement or made pursuant hereto shall remain in full force and effect regardless of any investigation (or statement as to the results
thereof) made by or on behalf of any holder of Registrable Securities, any director, officer or partner of such holder, any agent or underwriter
or any director, officer or partner thereof, or any controlling person of any of the foregoing, and shall survive delivery of and payment
for the Registrable Securities pursuant to the Purchase Agreement and the transfer and registration of Registrable Securities by such
holder and the consummation of an Exchange Offer.

 

(f)               
GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.

 

(g)              
Headings. The descriptive headings of the several Sections and paragraphs of this Agreement are inserted for convenience
only, do not constitute a part of this Agreement and shall not affect in any way the meaning or interpretation of this Agreement.

 

(h)              
Entire Agreement; Amendments. This Agreement and the other writings referred to herein (including, without limitation, the
Indenture and the form of Notes) or delivered pursuant hereto which form a part hereof contain the entire understanding of the parties
with respect to its subject matter. This Agreement supersedes all prior agreements and understandings between the parties with respect
to its subject matter. This Agreement may be amended and the observance of any term of this Agreement may be waived (either generally
or in a particular instance and either retroactively or prospectively) only by a written instrument duly executed by the Issuers and the
holders of at least a majority in aggregate principal amount of the Registrable Securities at the time outstanding. Each holder of any
Registrable Securities at the time or thereafter outstanding shall be bound by any amendment or waiver effected pursuant to this Section
9(h), whether or not any notice, writing or marking indicating such amendment or waiver appears on such Registrable Securities or is delivered
to such holder.

 

(i)                
Inspection. For so long as this Agreement shall be in effect, this Agreement and a complete list of the names and addresses
of all the holders of Registrable Securities shall be made available for inspection and copying, upon reasonable prior notice, on any
business day during normal business hours by any holder of Registrable Securities for proper purposes only (which shall include any purpose
related to the rights of the holders of Registrable Securities under the Notes, the Indenture and this Agreement) at the offices of the
Issuers at the address thereof set forth in Section 9(c) above and at the office of the Trustee under the Indenture.

 

    -26-

     

    

 

(j)                
 Counterparts. This Agreement may be executed by the parties in counterparts, each of which shall be deemed to be an original,
but all such respective counterparts shall together constitute one and the same instrument.

 

(k)              
Severability. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstances,
is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability of any such provision
in every other respect and of the remaining provisions hereof shall not be in any way impaired or affected thereby, it being intended
that all of the rights and privileges of the parties shall be enforceable to the fullest extent permitted by law.

 

(l)                
Securities Held by the Issuers, etc. Whenever the consent or approval of holders of a specified percentage of principal
amount of Registrable Securities or Exchange Notes is required hereunder, Registrable Securities or Exchange Notes, as applicable, held
by the Issuers or their affiliates (controlled by the Issuers and other than subsequent holders of Registrable Securities or Exchange
Notes if such subsequent holders are deemed to be affiliates solely by reason of their holdings of such Registrable Securities or Exchange
Notes) shall not be counted in determining whether such consent or approval was given by the holders of such required percentage.

 

(m)            
Additional Notes. Notwithstanding anything contained herein, any registration statement and exchange offer herein contemplated
may include other securities issued by the Issuers and guaranteed by the applicable guarantors, if any.

 

(n)              
Termination. The obligations of the Issuers under this Agreement to register or qualify the Registrable Securities or otherwise
make any offer shall terminate when there are no Registrable Securities outstanding.

 

[Signature Pages Follow]

 

    -27-

     

    

 

If the foregoing is in accordance with your understanding,
please sign and return to us counterparts hereof, and upon the acceptance hereof by you, on behalf of each of the Purchasers, this Agreement
and such acceptance hereof shall constitute a binding agreement among the parties hereto. It is understood that your acceptance of this
Agreement on behalf of each of the Purchasers is pursuant to the authority set forth in a form of agreement among Purchasers, the form
of which shall be submitted to the Issuers for examination upon request, but without warranty on your part as to the authority of the
signers thereof.

 

	 	Very truly yours,
	 	 
	 	CCO HOLDINGS, LLC, as an Issuer
	 	 
	 	By:	/s/ Scott Schwartz
	 	 	Name: Scott Schwartz
	 	 	Title:   Group Vice President, Corporate Finance and Treasurer
	 	 
	 	CCOH HOLDINGS CAPITAL CORP., as an Issuer
	 	 
	 	By:	/s/ Scott Schwartz
	 	 	Name: Scott Schwartz
	 	 	Title:   Group Vice President, Corporate Finance and Treasurer

 

Charter - Registration Rights Agreement

 

     

     

    

 

	 	Accepted as of the date hereof:
	 	 
	Acting on behalf of itself and	 
	the several Purchasers	 
	 	 
	By: DEUTSCHE BANK SECURITIES INC.	 
	 	 
	By:	/s/ Ian Dorrington	 
	 	Name: Ian Dorrington	 
	 	Title:   Managing Director	 
	 	 
	By:	/s/ Mike Guttilla	 
	 	Name: Mike Guttilla	 
	 	Title:   Director	 

 

Charter - Registration Rights Agreement

 

     

     

    

 

EXHIBIT A

 

CCO HOLDINGS, LLC

CCO HOLDINGS CAPITAL CORP.

INSTRUCTION TO DTC PARTICIPANTS

(Date of Mailing)

URGENT — IMMEDIATE ATTENTION REQUESTED

DEADLINE FOR RESPONSE: [DATE]1

 

The Depository Trust Company (“DTC”)
has identified you as a DTC Participant through which beneficial interests in the CCO Holdings, LLC (the “Company”)
and CCO Holdings Capital Corp. (together with the Company, the “Issuers”) 4.500% Senior Notes due 2033 (the “Notes”)
are held.

 

The Issuers are in the process of registering the
Notes under the Securities Act of 1933, as amended, for resale by the beneficial owners thereof. In order to have their Notes included
in the registration statement, beneficial owners must complete and return the enclosed Notice of Registration Statement and Selling Securityholder
Questionnaire.

 

It is important that beneficial owners of the Notes
receive a copy of the enclosed materials as soon as possible as their rights to have the Notes included in the registration statement
depend upon their returning the Notice and Questionnaire by [Deadline For Response]. Please forward a copy of the enclosed documents to
each beneficial owner that holds interests in the Notes through you. If you require more copies of the enclosed materials or have any
questions pertaining to this matter, please contact the Issuers c/o CCO Holdings, LLC, 400 Washington Boulevard, Stamford, Connecticut
06902, Attention: General Counsel.

 

 

 

		1	Not less than 28 calendar days from date of mailing.

 

    A-1

     

    

 

CCO HOLDINGS, LLC

CCO HOLDINGS CAPITAL CORP.

Notice of Registration Statement

and

Selling Securityholder Questionnaire

(Date)

 

Reference is hereby made to the Exchange and Registration
Rights Agreement (the “Exchange and Registration Rights Agreement”) among CCO Holdings, LLC (the “Company”),
CCO Holdings Capital Corp. (together with the Company, the “Issuers”), and the Purchasers named therein. Pursuant to
the Exchange and Registration Rights Agreement, the Issuers have filed with the United States Securities and Exchange Commission (the
 “Commission”) a registration statement on Form S-1 (the “Shelf Registration Statement”) for the
registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Issuers’
4.500% Senior Notes due 2033 (the “Notes”). A copy of the Exchange and Registration Rights Agreement is attached hereto.
All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Exchange and Registration Rights Agreement.

 

Each beneficial owner of Registrable Securities is
entitled to have the Registrable Securities beneficially owned by it included in the Shelf Registration Statement. In order to have Registrable
Securities included in the Shelf Registration Statement, this Notice of Registration Statement and Selling Securityholder Questionnaire
(“Notice and Questionnaire”) must be completed, executed and delivered to the Issuers’ counsel at the address
set forth herein for receipt ON OR BEFORE [Deadline for Response]. Beneficial owners of Registrable Securities who do not complete, execute
and return this Notice and Questionnaire by such date (i) will not be named as selling securityholders in the Shelf Registration Statement
and (ii) may not use the Prospectus forming a part thereof for resales of Registrable Securities.

 

Certain legal consequences arise from being named
as a selling securityholder in the Shelf Registration Statement and related prospectus. Accordingly, holders and beneficial owners of
Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being
named as a selling securityholder in the Shelf Registration Statement and related prospectus.

 

    A-2

     

    

 

ELECTION

 

The undersigned holder (the “Selling Securityholder”)
of Registrable Securities hereby elects to include in the Shelf Registration Statement the Registrable Securities beneficially owned by
it and listed below in Item (3). The undersigned, by signing and returning this Notice and Questionnaire, agrees to be bound with respect
to such Registrable Securities by the terms and conditions of this Notice and Questionnaire and the Exchange and Registration Rights Agreement,
including, without limitation, Section 6 of the Exchange and Registration Rights Agreement, as if the undersigned Selling Securityholder
were an original party thereto.

 

Upon any sale of Registrable Securities pursuant
to the Shelf Registration Statement, the Selling Securityholder will be required to deliver to the Issuers and the Trustee the Notice
of Transfer Pursuant to Registration Statement set forth in Exhibit B to the Exchange and Registration Rights Agreement.

 

The Selling Securityholder hereby provides the following
information to the Issuers and represents and warrants that such information is accurate and complete:

 

QUESTIONNAIRE

 

	(1)	(a)       Full Legal Name of Selling Securityholder:

 

(b)       Full
Legal Name of Registered Holder (if not the same as in (a) above) of Registrable Securities Listed in Item (3) below:

 

(c)       Full
Legal Name of DTC Participant (if applicable and if not the same as (b) above) Through Which Registrable Securities Listed in Item
(3) below are Held:

 

	(2)	Address for Notices to Selling Securityholder:

_______________________________

_______________________________

_______________________________

	 	Telephone:	_______________________________
	 	Fax:	_______________________________
	 	Contact Person:	_______________________________

 

	(3)	Beneficial Ownership of Notes:

Except as set forth below in this Item (3), the undersigned does not beneficially own any Notes.

 

		(a)	Principal amount of Registrable Securities beneficially owned:
	 	 	 

 

	 	 	CUSIP No(s). of such Registrable Securities:	 

 

		(b)	Principal amount of Notes other than Registrable Securities beneficially
owned:
	 	 	 

 

	 	 	CUSIP No(s). of such other Notes:  	 

 

    A-3

     

    

 

		(c)	Principal amount of Registrable Securities which the undersigned wishes to be included in the Shelf Registration Statement: _________________________________

 

	 	 	CUSIP No(s). of such Registrable Securities to be included in the Shelf Registration Statement: _________________________________________________

 

	(4)	Beneficial Ownership of Other Securities of the Issuers:

Except as set forth below in this Item (4), the undersigned Selling Securityholder is not the beneficial or registered owner of any other
securities of the Issuers other than the Notes listed above in Item (3).

 

State any exceptions here:

 

	(5)	Relationships with the Issuers:

Except as set forth below, neither the Selling Securityholder nor any of its affiliates, officers, directors or principal equity holders
(5% or more) has held any position or office or has had any other material relationship with the Issuers (or their respective predecessors
or affiliates) during the past three years.

 

State any exceptions here:

 

	(6)	Plan of Distribution:

Except as set forth below, the undersigned Selling Securityholder intends to distribute the Registrable Securities listed above in Item
(3) only as follows (if at all): Such Registrable Securities may be sold from time to time directly by the undersigned Selling Securityholder
or, alternatively, through underwriters, broker-dealers or agents. Such Registrable Securities may be sold in one or more transactions
at fixed prices, at prevailing market prices at the time of sale, at varying prices determined at the time of sale, or at negotiated prices.
Such sales may be effected in transactions (which may involve crosses or block transactions) (i) on any national securities exchange or
quotation service on which the Registrable Securities may be listed or quoted at the time of sale, (ii) in the over-the-counter market,
(iii) in transactions otherwise than on such exchanges or services or in the over-the-counter market, or (iv) through the writing of options.
In connection with sales of the Registrable Securities or otherwise, the Selling Securityholder may enter into hedging transactions with
broker-dealers, which may in turn engage in short sales of the Registrable Securities in the course of hedging the positions they assume.
The Selling Securityholder may also sell Registrable Securities short and deliver Registrable Securities to close out such short positions,
or loan or pledge Registrable Securities to broker-dealers that in turn may sell such Registrable Securities.

 

State any exceptions here:

 

    A-4

     

    

 

By signing below, the Selling Securityholder acknowledges
that it understands its obligation to comply, and agrees that it will comply, with the provisions of the Exchange Act including, without
limitation, Regulation M.

 

In the event that the Selling Securityholder transfers
all or any portion of the Registrable Securities listed in Item (3) above after the date on which such information is provided to the
Issuers, the Selling Securityholder agrees to notify the transferee(s) at the time of the transfer of its rights and obligations under
this Notice and Questionnaire and the Exchange and Registration Rights Agreement.

 

By signing below, the Selling Securityholder consents
to the disclosure of the information contained herein in its answers to Items (1) through (6) above and the inclusion of such information
in the Shelf Registration Statement and related Prospectus. The Selling Securityholder understands that such information will be relied
upon by the Issuers in connection with the preparation of the Shelf Registration Statement and related Prospectus.

 

In accordance with the Selling Securityholder’s
obligation under Section 3(e) of the Exchange and Registration Rights Agreement to provide such information as may be required by law
for inclusion in the Shelf Registration Statement, the Selling Securityholder agrees to promptly notify the Issuers of any inaccuracies
or changes in the information provided herein which may occur subsequent to the date hereof at any time while the Shelf Registration Statement
remains in effect. All notices hereunder and pursuant to the Exchange and Registration Rights Agreement shall be made in writing, by hand-delivery,
first-class mail, or air courier guaranteeing overnight delivery as follows:

 

(i)       To the Issuers:

_________________________

_________________________

_________________________

_________________________

_________________________

 

(ii)      With a copy to:

_________________________

_________________________

_________________________

_________________________

_________________________

 

Once this Notice and Questionnaire is executed by
the Selling Securityholder and received by the Issuers’ counsel, the terms of this Notice and Questionnaire, and the representations
and warranties contained herein, shall be binding on, shall inure to the benefit of and shall be enforceable by the respective successors,
heirs, personal representatives, and assigns of the Issuers and the Selling Securityholder (with respect to the Registrable Securities
beneficially owned by such Selling Securityholder and listed in Item (3) above). This Agreement shall be governed in all respects by the
laws of the State of New York without giving effect to any provisions relating to conflicts of laws.

 

    A-5

     

    

 

IN WITNESS WHEREOF, the undersigned, by authority
duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized agent.

 

Dated: ____________________

 

Selling Securityholder

(Print/type full legal name of beneficial owner of Registrable Securities)

 

	By:	 	 
	 	Name:	 
	 	Title:	 

 

PLEASE RETURN THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE FOR
RECEIPT ON OR BEFORE [DEADLINE FOR RESPONSE] TO THE ISSUERS’ COUNSEL AT:

 

_________________________

_________________________

_________________________

_________________________

_________________________

 

    A-6

     

    

 

EXHIBIT B

 

NOTICE OF TRANSFER PURSUANT TO REGISTRATION STATEMENT

 

CCO HOLDINGS, LLC

CCO HOLDINGS CAPITAL CORP.

400 Washington Boulevard

Stamford, Connecticut 06902

Attention: General Counsel

The Bank of New York Mellon Trust Company, N.A.

[Address]

Attention: Trust Officer

 

		Re:	CCO Holdings, LLC and CCO Holdings Capital Corp. (the “Issuers”) 4.500% Senior Notes
due 2033 (the “Notes”)

 

Please be advised that ________________ has transferred
$___________ aggregate principal amount of the above-referenced Notes pursuant to an effective Registration Statement on Form S-1 (File
No. 333-____) filed by the Issuers.

 

We hereby certify that the prospectus delivery requirements,
if any, of the Securities Act of 1933, as amended, have been satisfied and that the above-named beneficial owner of the Notes is named
as a “Selling Holder” in the prospectus dated [date] or in supplements thereto, and that the aggregate principal amount of
the Notes transferred are the Notes listed in such prospectus opposite such owner’s name.

 

Dated:

 

	 	Very truly yours,
	 	 
	 	 
	 	(Name)
	 	 
	 	By:	 
	 	(Authorized Signature)

 

    B-1exhibit41

Athene Annuity and Life Company      RIA II (01/22) RIA II (01/22)          Single Purchase  Payment Index-Linked  Deferred  Annuity Contract  • Periodic income commencing  on Annuity Date.  • The values of this Contract may be  affected by an external index;  however, this Contract does not  directly participate in any stock or  equity investments.  • Option to change Annuity Date.  • Non-Participating.  Athene Annuity and Life Company will make the payments  and provide the benefits described in this Contract in  consideration for the payment by the Owner of the Purchase  Payments when due.  The Company will pay the Death Benefit to the Beneficiary as  provided in this Contract if: (1) any Owner dies prior to the  Annuity Date, or (2) any Owner is a non-natural person and any  Annuitant dies prior to the Annuity Date.  This is a legal contract between the Owner and Athene  Annuity and Life Company.  The Company holds reserves for obligations under this  Contract in a separate account. The assets in the Separate  Account will not be chargeable with liabilities arising out of any  other business that the Company may conduct.  Contractual benefits and values for Index-Linked Segment  Options are variable, may increase or decrease, and are  not guaranteed as to a fixed dollar amount.  Please read your Contract carefully. It includes the  provisions both on the pages within and on any riders or  endorsements which are attached. If you are not satisfied  with your Contract, you may return it to the Company or to  the financial professional from whom your Contract was  purchased within [20] days following its receipt, and the  Purchase Payment paid, less any Withdrawals, will be  refunded, and your Contract will be cancelled. This is  referred to as the “Right to Cancel Period”.      Grant Kvalheim Blaine T. Doerrfeld  President Secretary        Administrative Office: Home Office:  Mail Processing Center 7700 Mills Civic Pkwy  P.O. Box 1555 West Des Moines, IA 50266-3862  Des Moines, IA 50306-1555 (888) 266-8489  (888) 266-8489  

 

Athene Annuity and Life Company    RIA II (01/22) Page i RIA II (01/22)  Table of Contents  Contract Schedule ............................................................................................................................ 1  Annuity Tables .................................................................................................................................. 1  1. Definitions ..................................................................................................................................... 3  Administrative Office ................................................................................................................ 3  Annuitant, Joint Annuitant ........................................................................................................ 3  Annuity Date ............................................................................................................................. 3  Beneficiary ............................................................................................................................... 3  Business Day ........................................................................................................................... 3  Company .................................................................................................................................. 3  Contract Anniversary ................................................................................................................ 3  Contract Date ........................................................................................................................... 3  Contract Year ........................................................................................................................... 3  Holding Account ....................................................................................................................... 3  Index or Indices ........................................................................................................................ 4  Index-Linked Segment Option .................................................................................................. 4  Owner, Joint Owners ................................................................................................................ 4  Segment Allocation Percentage ............................................................................................... 4  Segment Options ..................................................................................................................... 4  Segment End Date ................................................................................................................... 4  Segment Start Date .................................................................................................................. 4  Segment Term Period .............................................................................................................. 4  Separate Account ..................................................................................................................... 4  Strategy Endorsements ............................................................................................................ 5  Withdrawal ............................................................................................................................... 5  2. General Provisions ....................................................................................................................... 5  Annuity Payments .................................................................................................................... 5  Assignment .............................................................................................................................. 5  Change of Annuitant................................................................................................................. 6  Change of Beneficiary .............................................................................................................. 6  Contract .................................................................................................................................... 6  Conformity with Applicable Laws .............................................................................................. 6  Incontestability ......................................................................................................................... 6  Misstatement of Age or Gender ............................................................................................... 6  Ownership ................................................................................................................................ 7  

 

Athene Annuity and Life Company    RIA II (01/22) Page ii RIA II (01/22)  Notices ..................................................................................................................................... 7  Premium Taxes ........................................................................................................................ 7  Statements ............................................................................................................................... 7  3. Purchase Payment and Contract Value ........................................................................................ 7  Purchase Payment ................................................................................................................... 7  Contract Value ......................................................................................................................... 7  Interim Value ............................................................................................................................ 7  Segment Value ......................................................................................................................... 7  Segment Interim Value ............................................................................................................. 7  Segment Credits ...................................................................................................................... 8  Segment Allocation .................................................................................................................. 8  Segment Value Transfers ......................................................................................................... 8  4. Cash Surrender Value and Withdrawals ....................................................................................... 8  Cash Surrender Value .............................................................................................................. 8  Withdrawal Charge ................................................................................................................... 8  Withdrawals, Free Withdrawals ................................................................................................ 9  Required Minimum Distribution Withdrawals ............................................................................ 9  5. Death Provisions ........................................................................................................................ 10  Death Benefit ......................................................................................................................... 10  Beneficiary ............................................................................................................................. 10  Death of an Annuitant prior to the Annuity Date ..................................................................... 11  Death of an Owner prior to the Annuity Date .......................................................................... 11  Death on or after the Annuity Date ......................................................................................... 11  6. Settlement Options ..................................................................................................................... 11  Election of Option ................................................................................................................... 11  Settlement Options ................................................................................................................. 12  Option 1: Life Annuity ......................................................................................................... 12  Option 2: Life Annuity with Guaranteed Period .................................................................. 12  Option 3: Installment Refund Life Annuity .......................................................................... 12  Option 4: Joint and Last Survivor Annuity .......................................................................... 12  Option 5: Fixed Period Annuity .......................................................................................... 12  7. Termination................................................................................................................................. 12     For information, or to make a complaint regarding your Contract, call: [1-888-266-8489] 

 

Athene Annuity and Life Company    RIA II (01/22) Page 3 RIA II (01/22)  1. Definitions  In addition to the terms defined throughout this Contract, the following terms have the respective  meanings described in this section:  Administrative Office  Our Administrative Office is shown on the front of this Contract. We may change our Administrative  Office by notifying you in writing.  Annuitant, Joint Annuitant  The Annuitant is the natural person named on the Contract Schedule. The Annuitant is the person  whose life determines the annuity payments made under your Contract. We will allow you to name  two natural persons on the application to serve as Joint Annuitants.   Annuity Date  The Annuity Date is the date on which annuity payments will begin. The Annuity Date is the date  shown on the Contract Schedule and is the Contract Anniversary on or first following the later of the  Annuitant's age 95, or the 10th Contract Anniversary, unless modified by any rider or endorsement.  In the case of Joint Annuitants, the Annuity Date will be set based on the age of the older Joint  Annuitant. You may select an earlier Annuity Date, which may be any time after the Contract Date,  by notice provided to us. The revised Annuity Date must be at least 10 days after our receipt of your  notice.  Beneficiary  The Beneficiary is one or more persons or entities named by the Owner to receive the Death Benefit.  Business Day  Business Day means any day of the week except for Saturday, Sunday and U.S. federal holidays  where U.S. stock exchanges are closed.  Company  The Company and “we,” “us,” and “our” refer to Athene Annuity and Life Company.  Contract Anniversary  A Contract Anniversary is any 12-month anniversary of the Contract Date. For example, if the  Contract Date is January 10, 2022, then the first Contract Anniversary is January 10, 2023.  Contract Date  The Contract Date is the date your Contract is issued and is shown on the Contract Schedule.  Contract Year  A Contract Year is the 12-month period that begins on the Contract Date and each Contract  Anniversary. For example, if the Contract Date is January 17, 2022, then the first Contract Year is  the 12-month period between January 17, 2022 and January 16, 2023.  Holding Account  The Holding Account is an account that holds the Purchase Payment until it is allocated to the  applicable Segment Options according to the Segment Allocation Percentages selected by the  Owner. Interest is credited daily to the Holding Account in accordance with the Holding Account  Fixed Interest Rate. The Holding Account Fixed Interest Rate is an annual rate that is shown on the  Segment Contract Schedule and is guaranteed not to change.  

 

Athene Annuity and Life Company    RIA II (01/22) Page 4 RIA II (01/22)  Index or Indices  Index or Indices means the index or indices shown on the Segment Contract Schedule, which are  used in the calculation of the Segment Credits for an Index-Linked Segment Option.  Index-Linked Segment Option  Index-Linked Segment Option means any Segment Option that calculates Segment Credits based  on one or more underlying Indices (excludes Fixed Segment Options).  Owner, Joint Owners  Owner means one or more persons or entities named as owner in the application or their successor  or assignee per an assignment made in accordance with this Contract. If no owner is named on the  application, the Annuitant will be the Owner. If Joint Owners are named, all references to Owner  shall mean the Joint Owners. Joint Owners must be spouses. References to “you” and “your” refer  to the Owner.  Segment Allocation Percentage  A Segment Allocation Percentage is the percentage of the Purchase Payment applied to each  Segment Option.  Segment Options  A Segment Option is a method for crediting funds to your Contract. It includes a Segment Term  Period and an Index, if applicable. There may be several Segments Options available within any  Strategy Endorsement. The Segment Options available on the first available Segment Start Date  following your Contract Date are shown on the Segment Contract Schedule. You may transfer funds  across available Segment Options in accordance with the provisions of the Segment Value Transfers  section of this Contract.  Segment End Date  A Segment End Date is the last day of a Segment Term Period. The Segment Credit for Index-Linked  Segment Options is calculated on the Segment End Date. The Segment End Date coincides with  the next Segment Start Date.  Segment Start Date  The Segment Start Date is the first date of the Segment Term Period. The day and month on which  any Segment Start Date falls will always be the day and month shown in the Segment Contract  Schedule.  Segment Term Period  The Segment Term Period for each Segment Option is shown on the Segment Contract Schedule.  The Segment Term Period ends on the Segment End Date. Unless otherwise stated in a Strategy  Endorsement, upon expiration of each Segment Term Period a new Segment Term Period will begin.  Separate Account   The Separate Account is the segregated account, established by the Company under Iowa Law, in  which we hold reserves for our obligations under the Contract. The portion of the assets of the  Separate Account equal to the reserves and other Contract liabilities with respect to the Separate  Account will not be chargeable with liabilities arising out of any other business we may conduct. You  do not participate in the performance of assets held in the Separate Account and do not have any  direct claim on them. The Separate Account is not registered under the Investment Company Act of  1940.  

 

Athene Annuity and Life Company    RIA II (01/22) Page 5 RIA II (01/22)  Strategy Endorsements  Strategy Endorsements are separate documents that include additional terms of your Contract.  Withdrawal  Unless otherwise specified, a Withdrawal is the removal of funds from your Contract, including a  partial withdrawal, a surrender of your Contract, payment of a Death Benefit, or the application of  the Interim Value to a Settlement Option. A Withdrawal amount is the amount of Contract Value  withdrawn for such benefits, prior to the application of Withdrawal Charges, Interest Adjustments,  and Equity Adjustments. [We do not treat the deduction of the Segment Fee (defined in the Strategy  Endorsements) as a Withdrawal.]  2. General Provisions  Annuity Payments  Annuity payments will commence on the Annuity Date if:  • all Owners are natural persons and all the Owners and at least one Annuitant are alive on the  Annuity Date; or  • any Owner is a non-natural person and all Annuitants are alive on the Annuity Date.  Annuity payments will be paid to you or a payee you designate in accordance with the terms and  conditions of the Settlement Option elected by the Owner, or if no Settlement Option is elected, in  accordance with the terms and conditions of this Annuity Payments provision. In order for payments  to be made under this provision, an Annuitant must be living on the Annuity Date and on the date  that each following payment is due, if applicable, under the terms of the elected annuity Settlement  Option or the payment provisions below, if applicable. “Settlement Options” are the methods of  distribution described in the Settlement Options section of your Contract. We may require proof of  the correct age and gender of an Annuitant before making annuity payments.  An election of a Settlement Option must be made in writing by the Owner and is irrevocable on or  after the Annuity Date. If a Settlement Option has not been elected prior to the Annuity Date, one of  the following two payment provisions will apply:  • If there is one living Annuitant on the Annuity Date, the Interim Value will be applied to  provide annuity payments for the longer of the lifetime of the Annuitant or five years; or   • If there are two living Joint Annuitants on the Annuity Date, the Interim Value will be  applied to provide annuity payments in the same monthly amount for the longer of the lifetimes  of both Joint Annuitants or five years.  Assignment  We reserve the right to refuse our consent to any assignment at any time on a nondiscriminatory  basis if the assignment would violate or result in noncompliance with any applicable state or federal  law or regulation. Unless otherwise restricted by endorsement, you may request to assign or transfer  your rights under this Contract by notifying us. We will not be bound by an assignment until we  acknowledge it. If your Contract is assigned, the assignment will take effect on the date the notice  was signed, subject to any action taken by us before receipt of the notice. We have no liability under  any assignment for our actions or omissions done in good faith. In addition, we shall not be liable for  any tax consequences you may incur due to the assignment of your Contract.  

 

Athene Annuity and Life Company    RIA II (01/22) Page 6 RIA II (01/22)  Change of Annuitant  Before the Annuity Date, you may change the Annuitant by notifying us. A change will take effect as  of the date you signed the notice. The Annuitant may not be changed if this Contract is owned by a  non-natural person, unless the Contract is being continued by a surviving spouse as sole Beneficiary  in which case the surviving spouse Beneficiary will become the Annuitant. The Annuitant cannot be  changed on or after the Annuity Date.  Change of Beneficiary  Before the date the Death Benefit becomes payable, you may change a Beneficiary by notifying us.  You may name one or more contingent Beneficiaries. The interest of any named irrevocable  Beneficiary cannot be changed without the written consent of that Beneficiary. A change will take  effect as of the date you signed the notice. Any change is subject to payment or other action taken  by us before we received the notice.  Contract  This Contract, including the Contract Schedule, the Segment Contract Schedule, the attached  application, if any, and any attached endorsements, riders or signed amendments constitute the  entire Contract. No one except the President or Secretary of the Company may change or waive any  of the terms of this Contract. Any change must be in writing and signed by the President or the  Secretary of the Company.  Conformity with Applicable Laws  The benefits and Cash Surrender Value available under your Contract will not be less than the  minimum benefits required by statute or regulation as of the Contract Date in the state in which your  Contract is issued. If any provision of your Contract is determined not to provide the minimum  benefits, such provision will be deemed to be amended to conform or comply with such laws or  regulations. Notwithstanding any provision in your Contract to the contrary, all distributions under  your Contract must be made in accordance with the applicable requirements of section 72(s) of the  Internal Revenue Code, as amended, or section 401(a)(9), as amended, as applicable, and all terms  of your Contract will be interpreted consistently with the requirements of section 72(s) or section  401(a)(9), as applicable.  Incontestability  All statements made in the application are considered representations and not warranties. The  validity of your Contract will not be contestable.  Misstatement of Age or Gender  If the age of an Owner or Annuitant has been misstated and, as of the Contract Date, their correct  age exceeded the Maximum Issue Age, we will refund the Purchase Payment paid less any prior  Withdrawals or distributions and we will void this Contract. The Maximum Issue Age is shown on the  Contract Schedule.  If the age or gender of an Annuitant has been misstated (but the age as of the Contract Date did not  exceed the Maximum Issue Age), the amount we will pay will be that which the Purchase Payment  paid would have purchased if the correct age and gender had been stated. Age will be calculated as  the age at the last birthday of that Annuitant. Any underpayments made by us due to a misstatement  will be immediately paid in one sum with compounded interest. Any overpayments made by us will  be charged against the next succeeding annuity payment or payments with compounded interest.  

 

Athene Annuity and Life Company    RIA II (01/22) Page 7 RIA II (01/22)  Interest under this provision will be calculated based on the Misstatement Interest Rate shown on  the Contract Schedule.  Ownership  All rights described in your Contract may be exercised by you subject to the rights of any assignee  of record with us and any irrevocably named Beneficiary.  You may change an Owner by notifying us. A change will take effect as of the date you signed the  notice, unless you specify otherwise, subject to any payments made or actions taken by us prior to  receipt of this notice. We will not be liable for any tax consequences you may incur due to a change  of the Owner designation.  Notices  Unless stated otherwise, a valid notice or request from you to us must be in writing (or other form  acceptable to us), signed by you, and received and accepted at our Administrative Office.  Premium Taxes  Your state may charge us a premium tax for your Contract. We may deduct the amount of that tax  from your Purchase Payments when your Purchase Payments are received, or from the Contract  Value of your Contract upon:  • any Withdrawal from your Contract; or  • the election of a Settlement Option; or  • the payment of a Death Benefit.  Statements  We will furnish annually, and at any time upon your request, a statement reflecting Contract activity  and values.  3. Purchase Payment and Contract Value   Purchase Payment  The “Purchase Payment” is the amount we receive for your Contract, as shown on the Contract  Schedule, and is due on the Contract Date. Unless we approve otherwise, the maximum Purchase  Payment that we will accept for your Contract is $1,000,000.  No Purchase Payment will be accepted  after the Contract Date.  Contract Value  The “Contract Value” at any time is equal to the sum of the Segment Values.  Interim Value  The “Interim Value” at any time is equal to the sum of the Segment Interim Values.  Segment Value  The “Segment Value” of a Segment Option at any time is determined based on the provisions of the  applicable Strategy Endorsement.  Segment Interim Value  The “Segment Interim Value” of a Segment Option at any time is determined based on the provisions  of the Interim Value Endorsement.  

 

Athene Annuity and Life Company    RIA II (01/22) Page 8 RIA II (01/22)  Segment Credits  The dollar amounts we credit to each Segment Option under this Contract are called “Segment  Credits.” Segment Credits will be calculated for a Segment Option based on the provisions of the  applicable Strategy Endorsement.  Segment Allocation  On the Contract Date, the Purchase Payment will be credited to the Holding Account. The Holding  Account will be transferred to the Segment Options on the Segment Start Date based on the  Segment Allocation Percentages selected by the Owner. The Segment Allocation Percentages  selected for each Segment Option must be a whole percentage ranging from 0% to 100%. The sum  of the Segment Allocation Percentages must equal 100%.  Segment Value Transfers  At each Segment End Date that occurs before the Annuity Date, you may elect to transfer some or  all of the Segment Value from one of your Contract’s Segment Options into one or more of your  Contract’s other Segment Options, subject to any transfer limitations specified in your Contract’s  Strategy Endorsements. Each Segment Option involved in such transfers must be at the end of a  Segment Term Period. We will notify you at least [15] days prior to the Segment End Date of the  Cap Rates, Participation Rates, [Annual Spread,] and Annual Interest Rates applicable to available  Segment Options for the next Segment Term Period. Cap Rates, Participation Rates, [Annual  Spread,] and Annual Interest Rates are defined in the applicable Strategy Endorsements.  To elect such a transfer, you must notify us at least two Business Days before the Segment End  Date on which the transfer is to be made. Your notice must specify the Segment Options to which  each transfer is to be made. You must also specify the amount that is to be transferred, either as a  total dollar amount or as a whole percentage of the Segment Value of the Segment Option from  which the funds are being transferred.  For any transfer request we receive where the amount to be transferred represents a percentage of  a known or unknown value, we will use our best efforts to determine the amount that must be  transferred from each Segment Option in order to satisfy the intent of your original request.  4. Cash Surrender Value and Withdrawals  Cash Surrender Value  On or before the Annuity Date and before the date the Death Benefit becomes payable under this  Contract, you may surrender your Contract for the Cash Surrender Value, by making a written  request to our Administrative Office.  The “Cash Surrender Value” is the Interim Value adjusted for any applicable Withdrawal Charge.  Withdrawal Charge  Withdrawals may incur a charge if made during the Contract Years with a corresponding positive  rate as shown in the Withdrawal Charge Rate Schedule (that charge, a “Withdrawal Charge”; those  Contract Years, the “Withdrawal Charge Period”). The amount of the Withdrawal Charge is the  applicable rate from the Withdrawal Charge Rate Schedule multiplied by the Withdrawal amount.  The Withdrawal Charge Rate Schedule is set forth in your Contract Schedule.  The Withdrawal  Charge does not apply to the Free Withdrawal Amount.  

 

Athene Annuity and Life Company    RIA II (01/22) Page 9 RIA II (01/22)  Withdrawals, Free Withdrawals  On or before the Annuity Date and before the date the Death Benefit becomes payable under this  Contract, you may request a Withdrawal from your Contract. The Withdrawal amount, adjusted for  any applicable Withdrawal Charges, Interest Adjustment, and Equity Adjustment, cannot be greater  than the Cash Surrender Value. All Withdrawals will be subject to an Interest Adjustment and an  Equity Adjustment. The “Interest Adjustment” is a positive or negative adjustment that reflects  changes in interest rates related to the fixed income assets purchased in support of the Contract.  The “Equity Adjustment” is a positive or negative adjustment that reflects changes in economics  related to the Index. The Interest Adjustment and Equity Adjustment on any date are determined  based on the provisions of the Interim Value Endorsement.  Unless you direct otherwise, all partial Withdrawals will be taken first from the Fixed Segment  Options (shown on the Segment Contract Schedule), beginning with the Fixed Segment Option with  the shortest Segment Term Period. To the extent there are not enough funds in the Fixed Segment  Options to cover the entire Withdrawal, we will deduct the remaining balance from the other Segment  Options in which you have funds, beginning with Segment Options that have the shortest Segment  Term Period. If you have multiple Segment Options with the same Segment Term Period, we will  deduct the remaining balance pro rata across those Segment Options.  A “Free Withdrawal” is a Withdrawal amount on which no Withdrawal Charges apply. The Free  Withdrawal amount available to you in the first Contract Year will be equal to the Free Withdrawal  Percentage multiplied by the Purchase Payment. In subsequent Contract Years, the Free  Withdrawal amount available to you will be equal to the Free Withdrawal Percentage multiplied by  the Contract Value as of the Contract Anniversary on the first day of that Contract Year. The Free  Withdrawal Percentages are shown on the Contract Schedule. Any unused portion of the Free  Withdrawal amount for a Contract Year cannot be carried over to the following Contract Year.  If the amount of a Withdrawal in any Contract Year exceeds the Free Withdrawal amount for that  Contract Year, the excess Withdrawal will be subject to any applicable Withdrawal Charge. If you  surrender your Contract, a Withdrawal Charge will be applied to any Free Withdrawal previously  taken during the same Contract Year.  To take a Withdrawal from your Contract, you must notify us. The minimum amount that you may  request to be withdrawn from your Contract at any time is $500. If you request a Withdrawal that  causes the Contract Value to be less than $2,000, we will treat your request as a surrender of your  Contract. We reserve the right to pay Withdrawal amounts directly to you. We may defer payment of  any Withdrawals of any type from your Contract for up to six months if the insurance regulatory  authority of the state in which your Contract was issued approves the deferral.  Required Minimum Distribution Withdrawals  This provision applies only if your Contract is subject to the minimum distribution requirements under  Internal Revenue Code section 401(a)(9), such as if this Contract is a contract issued in connection  with a qualified plan under section 401(a), a section 403(b) contract, an individual retirement annuity  contract under section 408, or a Roth IRA under section 408A.  Any Withdrawal of a required minimum distribution under section 401(a)(9) with respect to this  Contract, as calculated by us, will not be subject to Withdrawal Charges. Any required minimum  distribution Withdrawal amount includes and is not in addition to the Contract's Free Withdrawal  amount. If the Owner surrenders the Contract, a Withdrawal Charge will be applied to any Free  

 

Athene Annuity and Life Company    RIA II (01/22) Page 10 RIA II (01/22)  Withdrawal previously taken during the same Contract Year, including any required minimum  distribution Withdrawals. Required minimum distributions will incur a Withdrawal Charge if you  previously took a Withdrawal in the same Contract Year to satisfy the required minimum distribution  requirement. In this circumstance, you must wait until the next Contract Anniversary to take your  required minimum distribution free of Withdrawal Charges.  5. Death Provisions  Death Benefit  The “Death Benefit” will be equal to the Interim Value. The Death Benefit will be calculated as of the  date of death. Withdrawal Charges will not be applied in determining the Death Benefit payable to  your Beneficiary. If applicable law requires the payment of interest on the Death Benefit, the Death  Benefit will earn interest at a rate and in the manner required by law. The Death Benefit must be  paid in a manner that complies with the applicable requirements of section 72(s) of the Internal  Revenue Code.  Before we will pay the Death Benefit, we must receive a claim at our Administrative Office in a form  and manner satisfactory to us, which includes:  • proof of death while the Contract was in effect;   • our claim form properly completed from each Beneficiary, as applicable; and  • any other documents required by law.  Beneficiary  The following rules apply unless otherwise permitted by us in accordance with applicable law:  • No Beneficiary has any rights in your Contract until the Beneficiary is entitled to the Death  Benefit. If the Beneficiary, including an irrevocable Beneficiary, dies before that time, all rights  of that Beneficiary will end at their death.  • If no Beneficiary has been named or if no Beneficiary is alive at the time the Death Benefit is  payable, then the Beneficiary is the estate of the deceased Owner or Annuitant whose death  caused the Death Benefit to be payable. If the death of both Joint Annuitants or Joint Owners,  if applicable, occurs simultaneously, the estates of both will be the Beneficiary in equal shares.  This paragraph does not apply if there is a named Beneficiary and such Beneficiary is an  entity.  • If you have not designated how the Death Benefit is to be distributed and two or more  Beneficiaries are entitled to the Death Benefit, the Death Benefit will be paid to the  Beneficiaries in equal shares.  • Unless you notify us otherwise, if you have designated how the Death Benefit is to be  distributed and a Beneficiary dies prior to the time such Beneficiary is entitled to the Death  Benefit, the portion of the Death Benefit designated to the deceased Beneficiary will be  divided among the surviving Beneficiaries and Beneficiaries that are entities on a pro rata  basis. In other words, each surviving Beneficiary's or each entity Beneficiary’s interest in the  Death Benefit will be divided by the sum of the interests of all such surviving or entity  Beneficiaries to determine the percentage each Beneficiary will receive of the deceased  Beneficiary's original interest in the Death Benefit.  

 

Athene Annuity and Life Company    RIA II (01/22) Page 11 RIA II (01/22)    Death of an Annuitant prior to the Annuity Date  If the Annuitant is not an Owner and dies prior to the Annuity Date, you may designate a new  Annuitant, subject to our underwriting rules then in effect. If no designation is made within 30 days  of death of the Annuitant, the younger of you or any Joint Owner will become the Annuitant.  If the Owner is a non-natural person, the death of the Annuitant will be treated as the death of the  Owner and a new Annuitant may not be designated.  Death of an Owner prior to the Annuity Date  If any Owner (or, if the Owner is a non-natural person, any Annuitant) dies prior to the Annuity Date,  we will pay the Death Benefit to the Beneficiary.  Upon the death of any Joint Owner, where the surviving spouse is the surviving Joint Owner, the  surviving Joint Owner will become the sole designated Beneficiary to whom the Death Benefit will  be paid, and any other Beneficiary designation on record at the time of the death will be treated as  a contingent Beneficiary. If the Beneficiary is a natural person, that Beneficiary may elect for the  Death Benefit to be distributed over the life of the Beneficiary, or over a period not extending beyond  the life expectancy of the Beneficiary, provided the election is made in accordance with Internal  Revenue Code section 72.  If the sole Beneficiary is the deceased Owner’s surviving spouse (or, if the Owner is a non-natural  person, the deceased Annuitant’s surviving spouse), the surviving spouse may elect to continue the  Contract as the sole Owner in lieu of receiving the Death Benefit. This provision relating to the  surviving spouse can only apply once and cannot apply a second time if the surviving spouse elects  to continue the Contract, remarries and then dies.  All elections must be made by submitting the appropriate notice to us.  Death on or after the Annuity Date  If an Owner dies (or an Annuitant dies where the Owner is a non-natural person) on or after the  Annuity Date and before the entire interest in this Contract has been distributed, any remaining  interest in this Contract will be distributed under the method of distribution being used on the date of  death.  6. Settlement Options  Election of Option  On the Annuity Date, the Interim Value will be applied to provide annuity payments to you or a payee  you designate in accordance with the applicable Settlement Option elected by the Owner or if no  Settlement Option was elected, in accordance with the Annuity Payments provision. Withdrawal  Charges will not be applied when you elect a Settlement Option and will not be applied to the  resulting annuity payments. As stated in the Annuity Payments provision, an election of a Settlement  Option must be made in writing by the Owner prior to the Annuity Date and is irrevocable as of the  Annuity Date.  Additionally, the Beneficiary may elect to receive the Death Benefit under one of the Settlement  Options described below, subject to the satisfaction of section 72(s) of the Internal Revenue Code,  as amended. Any election of a Settlement Option by a Beneficiary must be made in writing and is  irrevocable as of the date payments begin. For purposes of the Settlement Options below, the  Beneficiary will be the Annuitant.  

 

Athene Annuity and Life Company    RIA II (01/22) Page 12 RIA II (01/22)  A lump sum along with a Settlement Option may be elected. The amount applied under the  Settlement Option must be at least $5,000. Payments made quarterly, semiannually, or annually  may be elected in lieu of monthly payments. Payments less than $100 will only be made annually.  Settlement Options  No future payments under any option except as provided in the Settlement Option or by law may be  assigned or transferred. In addition to the Settlement Options below, we may provide other options  at our discretion:  Option 1: Life Annuity  Monthly payments will be made during the lifetime of the Annuitant. The monthly payments will  cease on the death of the Annuitant. No payments will be due after the death of the Annuitant.  Option 2: Life Annuity with Guaranteed Period  Monthly payments will be made for the longer of the guaranteed period elected and the lifetime  of the Annuitant. The guaranteed periods are 5, 10, 15 or 20 years, or any other period agreed  upon in writing by us. After the guaranteed period, monthly payments will cease on the death of  the Annuitant, and no payments will be due after the death of the Annuitant. If the Annuitant dies  during the guaranteed period, no payments will be due after the guaranteed period.  Option 3: Installment Refund Life Annuity  Monthly payments will be made for the Installment Refund Period and thereafter for the lifetime  of the Annuitant. The “Installment Refund Period” is the period required for the sum of the monthly  payments to equal the total amount applied under this option. After the Installment Refund Period,  monthly payments will cease on the death of the Annuitant, and no payments will be due after  the death of the Annuitant. If the Annuitant dies during the Installment Refund Period, no  payments will be due after the Installment Refund Period.  Option 4: Joint and Last Survivor Annuity  Monthly payments will be made for the joint lifetime of two Annuitants and in an equal amount  during the remaining lifetime of the survivor. Payments will cease, and no further payments will  be due, on the death of the last survivor. Payments may also be made to the survivor in an  amount equal to two-thirds or one-half of the payment made during the joint lifetime of the two  persons.  We will furnish Annuity Settlement Option factors for Option 4 upon request.  Option 5: Fixed Period Annuity  Monthly payments will be made for the fixed period elected. Payments will cease at the end of  the fixed period and no further payments will be due. The fixed period that may be elected is any  period from 5 to 30 years. Fixed periods shorter than 10 years are only available as a Death  Benefit Settlement Option.  Annuity Settlement Option factors for Options 1, 2, 3, and 5 are shown on the Contract Schedule.  7. Termination  Your Contract will terminate on the date on which all amounts are paid as required by your Contract. 

 

Athene Annuity and Life Company    RIA II (01/22)  RIA II (01/22)  Single Purchase Payment Index-Linked Deferred Annuity Contract  Subject to the terms and conditions of your Contract, periodic income commencing on the Annuity  Date with the option to change the type of Settlement Option payable prior to the Annuity Date. Non- Participating.     Administrative Office: Home Office:   Mail Processing Center 7700 Mills Civic Pkwy   P.O. Box 1555 West Des Moines, IA 50266-3862   Des Moines, IA 50306-1555 (888) 266-8489   (888) 266-8489                            

 

Athene Annuity and Life Company    CS II (01/22) Page 1 CS II (01/22)  Contract Schedule    Contract Number: [Specimen] Purchase Payment: $[10,000.00]  Annuitant: [John Doe] Age: [35] Gender: [Male]  [Joint Annuitant: [Jane Doe] Age: [35] Gender: [Female]]  Owner: [John Smith] Age: [75] Gender: [Male]  [Joint Owner: [Jane Smith] Age: [75] Gender: [Female]]  Contract Date: [01/10/2018]  Maximum Issue Age: [80]  Annuity Date: [01/10/2058]  Misstatement Interest Rate: [1.00%]    Withdrawal Charge Rate Schedule  Free Withdrawal Percentage Schedule  [Contract Year Rate  [Contract Year Rate  1 8.00%  1 10.00%  2 8.00%  2 10.00%  3 7.00%  3 10.00%  4 6.00%  4 10.00%  5 5.00%  5 10.00%  6 4.00%  6 10.00%  7+ 0.00%]  7+ 100.00%]    Annuity Tables  The guaranteed monthly income rates for the Settlement Options are set forth in the tables below  and are based on an interest rate of [0.50]% and where lifespan affects the payout, the [2012  ANB IAM Period Table developed by the Society of Actuaries, with gender-specific rates, and  with 10 years of generational mortality improvement applied using Projection Scale G2]. If we are  required to use the same income rates for males and females, the guaranteed monthly income  rates for the Settlement Options where lifespan affects the payout assume that Annuitants are  60% female and 40% male. We may offer guaranteed monthly income rates that are more  favorable than those contained in your Contract.  Males - Option One, Two and Three  Monthly Income Rates per $1,000   Period Certain & Life  Age Life 5 Years 10 Years 15 Years 20 Years Installment Refund  60 [3.10 3.10 3.07 3.03 2.96 2.66  65 3.66 3.65 3.60 3.51 3.37 3.02  70 4.45 4.42 4.31 4.11 3.80 3.49  75 5.61 5.53 5.26 4.78 4.14 4.10  80 7.41 7.16 6.41 5.34 4.32 4.93  85+ 10.27 9.45 7.50 5.65 4.37 6.06]     

 

Athene Annuity and Life Company    CS II (01/22) Page 2 CS II (01/22)  Females - Option One, Two and Three  Monthly Income Rates per $1,000   Period Certain & Life  Age Life 5 Years 10 Years 15 Years 20 Years Installment Refund  60 [2.95 2.94 2.92 2.89 2.84 2.57  65 3.45 3.44 3.41 3.34 3.24 2.90  70 4.14 4.12 4.05 3.90 3.66 3.31  75 5.15 5.10 4.91 4.56 4.04 3.86  80 6.71 6.55 6.01 5.17 4.28 4.59  85+ 9.15 8.59 7.14 5.57 4.36 5.59]    Non gender-specific - Option One, Two and Three  Monthly Income Rates per $1,000   Period Certain & Life  Age Life 5 Years 10 Years 15 Years 20 Years Installment Refund  60 [3.01 3.00 2.99 2.95 2.89 2.60  65 3.54 3.53 3.49 3.41 3.29 2.94  70 4.27 4.24 4.16 3.99 3.72 3.38  75 5.34 5.28 5.06 4.65 4.09 3.95  80 6.99 6.80 6.18 5.24 4.30 4.72  85+ 9.60 8.94 7.30 5.61 4.36 5.78]    Option Five1  Monthly Income Rates per $1,000 of  Proceeds  Number of Years Monthly Payment  5 [16.87  10 8.54  15 5.76  20 4.38  25 3.54  30 2.99]  1 Fixed periods shorter than 10 years are only   available as a Death Benefit Settlement Option.    Blaine T. Doerrfeld  Secretary  

 

Confinement Waiver of Withdrawal Charges           Athene Annuity and Life Company    CW II (01/22) Page 1  CW II (01/22)  CONFINEMENT WAIVER OF WITHDRAWAL CHARGES   Part of the Contract  This endorsement is part of your Contract and is subject to all terms and conditions of your Contract.  Any capitalized terms not defined in this endorsement are defined in the Contract. To the extent  there are any conflicts between this endorsement and your Contract, this endorsement will control.  The effective date of this endorsement for new Contracts is the Contract Date and for existing  Contracts is the date we issue this endorsement.   Confinement Waiver  After the [first] Contract Year and on or before the Annuity Date and before the date the Death Benefit  becomes payable under the Contract, you may request a payment equal to an amount up to your  Contract’s Interim Value if, at the time of the request, all of the following conditions are met:  • any Owner, (or if the Owner is a non-natural person, any Annuitant), is confined to a Qualified  Care Facility; and  • confinement continues for at least 60 consecutive days; and  • confinement begins at least [one] year[s] after the Contract Date; and  • confinement is recommended in writing by a Physician; and   • we receive the withdrawal request and the Physician's recommendation no later than 90 days  following the date the confinement has ceased.  Any payment made under this provision will not be subject to Withdrawal Charges. Any applicable  Interest Adjustment or Equity Adjustment will still apply.  A “Qualified Care Facility” means a Convalescent Care Facility, Hospice Facility or Hospital as  described below:  • “Convalescent Care Facility” means an institution which: (i) is licensed by the State as a  convalescent nursing facility, a qualified nursing facility, a convalescent hospital, a  convalescent unit of a Hospital, an intermediate care facility, or a custodial care facility; and  (ii) is primarily engaged in providing, in addition to room and board accommodations,  continuous nursing service by or under the supervision of a Physician or a licensed registered  nurse (R.N.); and (iii) maintains a daily record of each patient which is available for our review;  and (iv) administers a planned program of observation and treatment by a Physician (which  for purposes of this provision also cannot be the proprietor or an employee of such facility)  which is in accordance with existing standards of medical practice for the confinement.  Convalescent Care Facility does not mean a facility or any part of a facility used primarily for  rest care, training or education, or the treatment of alcoholism or chemical dependency.  • “Hospice Facility” means an institution which provides a formal program of care for terminally  ill patients whose life expectancy is less than six months, provided on an inpatient basis and  directed by a Physician. It must be licensed, certified, or registered in accordance with State  law.  • “Hospital” means an institution which: (i) is licensed as a hospital and operated pursuant to  law; and (ii) is primarily engaged in providing or operating (either on its premises or in facilities  available to the hospital on a prearranged contractual basis and under the supervision of a  staff of one or more duly licensed Physicians) diagnostic and surgery facilities for the medical  care and treatment of injured and sick persons on an inpatient basis for which a charge is  

 

Confinement Waiver of Withdrawal Charges           Athene Annuity and Life Company    CW II (01/22) Page 2  CW II (01/22)  made; and (iii) provides 24-hour nursing service by or under the supervision of a licensed  registered nurse (R.N.).  Hospital does not mean a facility or any part of a facility used primarily for rest care, training  or education, or the treatment of alcoholism or chemical dependency.  “Physician” for purposes of this provision means a doctor of medicine or osteopathy legally  authorized to practice medicine by the State in which he/she performs such function. The Physician  cannot be you, an Annuitant, a Beneficiary, or a member of your, an Annuitant’s, or a Beneficiary’s  immediate family, including a husband, wife, domestic partner, civil union partner, child, sibling,  parent, grandparent, grandchild, cousin, aunt, uncle, niece, nephew and any of their spouses,  domestic partners or civil union partners.    “State” for purposes of this endorsement means each state of the United States of America, as well  as the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam and  American Samoa.   We reserve the right to obtain, at any time, an additional opinion or an examination of the ill Owner  from a Physician that we designate at our expense.  Should this opinion differ from that of the ill  Owner’s Physician, the opinion of our Physician will prevail.  This provision will terminate upon the change or addition of an Owner (or if the Owner is a non- natural person and the Annuitant is changed or an additional Annuitant is added), except through  continuation of the Contract by the surviving spouse.  Denial of Waiver  If we deny a confinement waiver claim, the Withdrawal will not be disbursed until the Owner is notified  of the denial and provided the opportunity to accept or reject the Withdrawal proceeds after any  Withdrawal Charge.   Termination  Termination of this Contract shall not prejudice the waiver of any Withdrawal Charges while this  Confinement Waiver was in force.      Blaine T. Doerrfeld  Secretary  

 

Terminal Illness Waiver of Withdrawal Charges          Athene Annuity and Life Company    TIW II (01/22) Page 1  TIW II (01/22)  TERMINAL ILLNESS WAIVER OF WITHDRAWAL CHARGES  Part of the Contract  This endorsement is part of your Contract and is subject to all terms and conditions of your Contract.  Any capitalized terms not defined in this endorsement are defined in the Contract. To the extent  there are any conflicts between this endorsement and your Contract, this endorsement will control.  The effective date of this endorsement for new Contracts is the Contract Date and for existing  Contracts is the date we issue this endorsement.   Terminal Illness Waiver  After the [first] Contract Year and on or before the Annuity Date and before the date the Death Benefit  becomes payable under the Contract, you may request a payment equal to an amount up to your  Contract’s Interim Value if, at the time of the request, all of the following conditions are met:  • any Owner, (or if the Owner is a non-natural person, any Annuitant), is diagnosed with a  Terminal Illness; and  • the initial diagnosis occurs at least [one] year[s] after the Contract Date; and  • the withdrawal request is accompanied by a certification of Terminal Illness prepared by a  Physician who has examined the ill Owner and is qualified to provide the certification.  Any payment made under this provision will not be subject to Withdrawal Charges. Any applicable  Interest Adjustment or Equity Adjustment will still apply.  “Terminal Illness” means an illness that is expected to cause death within 12 months.  “Physician” for purposes of this provision means a doctor of medicine or osteopathy legally  authorized to practice medicine by the state in which he/she performs such function. The Physician  cannot be you, an Annuitant, a Beneficiary, or a member of your, an Annuitant’s, or a Beneficiary’s  immediate family, including a husband, wife, domestic partner, civil union partner, child, sibling,  parent, grandparent, grandchild, cousin, aunt, uncle, niece, nephew and any of their spouses,  domestic partners or civil union partners. “State” for purposes of this provision means each state of  the United States of America, as well as the District of Columbia, the Commonwealth of Puerto Rico,  the Virgin Islands, Guam and American Samoa.   We reserve the right to obtain, at any time, an additional opinion or an examination of the ill Owner  from a Physician that we designate at our expense. Should this opinion differ from that of the ill  Owner’s Physician, the opinion of our Physician will prevail.  This provision will terminate upon the change or addition of an Owner (or if the Owner is a non- natural person and the Annuitant is changed or an additional Annuitant is added), except through  continuation of the Contract by the surviving spouse.  Denial of Waiver  If we deny a Terminal Illness waiver claim, the Withdrawal will not be disbursed until the Owner is  notified of the denial and provided the opportunity to accept or reject the Withdrawal proceeds after  any Withdrawal Charge.  

 

Terminal Illness Waiver of Withdrawal Charges          Athene Annuity and Life Company    TIW II (01/22) Page 2  TIW II (01/22)  Termination   Termination of this Contract shall not prejudice the waiver of any Withdrawal Charges while this  Terminal Illness Waiver was in force.            Blaine T. Doerrfeld  Secretary                          

 

Athene Annuity and Life Company    SCS II (01/22) Page 1 SCS II (01/22)  Segment Contract Schedule  [Segment Allocation Guidelines  On the Contract Date, you may select:  • Up to [1] Fixed Segment Option[s];   • Up to [16] Buffer Segment Option[s];   • Up to [1] Buffer Milestone Segment Option[s]; and  • Up to [1] Buffer Multi-Index Segment Option[s].]   Substitution or Discontinuation of an Index  If an Index is discontinued, if we are engaged in a contractual dispute with the Index provider, if we  are unable to utilize it in any Segment Option on commercially reasonable terms, or if the calculation  of the Index is changed substantially, we will either discontinue the Index or substitute a suitable  Index for that Index and provide you 30 days’ prior notice of the change at your last known address  on file with us. Any substitute Index will be submitted for prior approval to the insurance regulatory  authority of the state in which your Contract is issued. If no substitute Index is provided, the Segment  Value will be automatically transferred to the Fixed Segment Option on the scheduled Segment End  Date, unless you elect to have the Segment Value transferred to one or more of the available  Segment Options by providing us notice, as provided for in the Segment Value Transfers provision  of the Contract.  If we discontinue any Index during a Segment Term Period and substitute a similar Index, Segment  Credits will be determined as follows:  (1)      For any Buffer Milestone Segment Option, until a Milestone Credit Percentage is determined  after the Index substitution, we will determine each potential Milestone Credit Percentage by: (i)  adding together the percentage change in the Index Price of the original Index from the most recent  Milestone Date until the date of the substitution and then measuring the percentage change in the  Index Price of the substituted Index from the date of the substitution until the current Observation  Date; and (ii) if a Milestone Credit Percentage is determined, applying the then-current Cap Rate,  Participation Rate, and Buffer Rate if applicable. Once a Milestone Credit Percentage has been  determined (and a Milestone Date is set) after the Index substitution, only the substituted index will  be used to measure the Milestone Index Change for any future Observation date during the Segment  Term Period. Any previously determined Milestone Credit Percentages will also be used in the  calculation of the Segment Credit.   (2)     For all other Index-Linked Strategies, we will determine the Index Change for the Segment  Term Period by: (i) adding together the percentage change in the Index Price of the original Index  from the Segment Start Date until the date of the substitution and the percentage change in the  Index Price of the substituted Index from the date of the substitution until the Segment End Date;  and (ii) applying the then-current Cap Rate, Participation Rate, and Buffer Rate to that sum. The  substituted Index will be incorporated in the Buffer Multi-Index Segment Option, if applicable.   (3)      For all Index-Linked Segment Options, the resulting Segment Credit will be added to your  Segment Value on the scheduled Segment End Date.     

 

Athene Annuity and Life Company    SCS II (01/22) Page 2 SCS II (01/22)  If we discontinue any Index during a Segment Term Period and do not substitute a similar Index,  Segment Credits will be determined as follows:  (1)    For any Buffer Milestone Segment Option, we will determine the final Milestone Credit  Percentage for the Segment Term Period by (i) adding together the percentage change in the Index  Price from the most recent Milestone Date until the date of discontinuation; and (ii) applying the then- current Cap Rate, Participation Rate, and Buffer Rate if applicable.  Any previously determined  Milestone Credit Percentages will also be used in the calculation of the Segment Credit.   (2)      For all other Index-Linked Strategies, we will calculate the Segment Credit as of the date the  Index is discontinued (including for the Buffer Multi-Index Segment Option, if any of the three Indices  is affected). The Segment Credit will be based on (i) the percentage change of the Index Price from  the Segment Start Date to the date of discontinuation; and (ii) the then-current Cap Rate,  Participation Rate, and Buffer Rate.   (3)      For all Index-Linked Segment Options, the resulting Segment Credit will be added to your  Segment Value on the scheduled Segment End Date.   Holding Account Fixed Interest Rate: [1.00%]   Segment Start Date: [February] [8], [2022]  [Segment Fee for all Index-Linked Segment Options: [0.95%]]  [Fixed Segment Option]        Segment  Term Period  Minimum Annual  Interest Rate  Initial Segment Term  Period Bailout  Annual Interest Rate  [1] Year[s] [1.00]% [1.00]%  

 

Athene Annuity and Life Company    SCS II (01/22) Page 3 SCS II (01/22)  [Buffer Segment Options]  Index  Segment  Term  Period  Buffer  Rate  Minimum  Cap Rate  [Maximum  Annual  Spread]  Minimum  Participation  Rate  [S&P 500® (SPX)] [1] Year[s] [10.00]% [2.00]% [1.00]% [100]%  [Russell 2000® (RTY)] [1] Year[s] [10.00]% [2.00]% [1.00]% [100]%  [MSCI EAFE (MXEA)] [1] Year[s] [10.00]% [2.00]% [1.00]% [100]%  [Nasdaq-100® (NDX)] [1] Year[s] [10.00]% [2.00]% [1.00]% [100]%  [Shiller Barclays CAPE® US Mid- Month Sector TR Net (BXIIMSTN)]  [1] Year[s] [10.00]% [2.00]% [1.00]% [100]%  [S&P 500® (SPX)] [1] Year[s] [20.00]% [2.00]% [1.00]% [100]%  [S&P 500® (SPX)] [2] Year[s] [10.00]% [4.00]% [1.00]% [100]%  [Russell 2000® (RTY)] [2] Year[s] [10.00]% [4.00]% [1.00]% [100]%  [MSCI EAFE (MXEA)] [2] Year[s] [10.00]% [4.00]% [1.00]% [100]%  [Nasdaq-100® (NDX)] [2] Year[s] [10.00]% [4.00]% [1.00]% [100]%  [Shiller Barclays CAPE® US Mid- Month Sector TR Net (BXIIMSTN)]  [2] Year[s] [10.00]% [4.00]% [1.00]% [100]%  [S&P 500® (SPX)] [2] Year[s] [20.00]% [4.00]% [1.00]% [100]%  [S&P 500® (SPX)] [6] Year[s] [20.00]% [12.00]% [1.00]% [100]%  [Nasdaq-100® (NDX)] [6] Year[s] [20.00]% [12.00]% [1.00]% [100]%  [Shiller Barclays CAPE® US Mid- Month Sector TR Net (BXIIMSTN)]  [6] Year[s] [20.00]% [12.00]% [1.00]% [100]%  [S&P 500® (SPX)] [6] Year[s] [30.00]% [12.00]% [1.00]% [100]%    Index  Segment  Term Period  Buffer  Rate  Initial Segment Term  Period Bailout  Cap Rate  Participation  Rate  [S&P 500® (SPX)] [1] Year[s] [10.00]% [2.00]% [100]%  [Russell 2000® (RTY)] [1] Year[s] [10.00]% [2.00]% [100]%  [MSCI EAFE (MXEA)] [1] Year[s] [10.00]% [2.00]% [100]%  [Nasdaq-100® (NDX)] [1] Year[s] [10.00]% [2.00]% [100]%  [Shiller Barclays CAPE® US Mid-Month  Sector TR Net (BXIIMSTN)]  [1] Year[s] [10.00]% [2.00]% [100]%  [S&P 500® (SPX)] [1] Year[s] [20.00]% [2.00]% [100]%  [S&P 500® (SPX)] [2] Year[s] [10.00]% [4.00]% [100]%  [Russell 2000® (RTY)] [2] Year[s] [10.00]% [4.00]% [100]%  [MSCI EAFE (MXEA)] [2] Year[s] [10.00]% [4.00]% [100]%  [Nasdaq-100® (NDX)] [2] Year[s] [10.00]% [4.00]% [100]%  [Shiller Barclays CAPE® US Mid-Month  Sector TR Net (BXIIMSTN)]  [2] Year[s] [10.00]% [4.00]% [100]%  [S&P 500® (SPX)] [2] Year[s] [20.00]% [4.00]% [100]%  [S&P 500® (SPX)] [6] Year[s] [20.00]% [12.00]% [100]%  [Nasdaq-100® (NDX)] [6] Year[s] [20.00]% [12.00]% [100]%  [Shiller Barclays CAPE® US Mid-Month  Sector TR Net (BXIIMSTN)]  [6] Year[s] [20.00]% [12.00]% [100]%  [S&P 500® (SPX)] [6] Year[s] [30.00]% [12.00]% [100]%    

 

Athene Annuity and Life Company    SCS II (01/22) Page 4 SCS II (01/22)  [Buffer Milestone Segment Option[s]]  Index  Segment  Term Period  Buffer  Rate  Observation  Interval  Milestone  Threshold  Minimum  Cap Rate  Minimum  Participation  Rate  [S&P 500® (SPX)] [6] Year[s] [15.00]% [1 Year[s]] [25.00]% [12.00]% [100]%    Index  Segment  Term Period  Buffer  Rate  Observation  Interval  Initial Segment Term   Period Bailout  Cap Rate  Participation  Rate  [S&P 500® (SPX)] [6] Year[s] [15.00]% [1 Year[s]] [12.00]% [100]%    [Buffer Multi-Index Segment Option[s]]  Index  Index Allocation  Percentage  Segment  Term  Period  Buffer  Rate  Minimum  Cap Rate  [Maximum  Annual  Spread]  Minimum  Participation  Rate  Index X: [(SPX)]  Index Y: [(RTY)]  Index Z: [(MXEA)]  Allocation 1 [50%]  Allocation 2 [30%]  Allocation 3 [20%]  [6] Year[s]    [10.00]%    [12.00]% [1.00]% [100]%    Index  Index Allocation  Percentage  Segment  Term Period  Buffer  Rate  Initial Segment Term   Period Bailout  Cap Rate Participation  Rate  Index X: [(SPX)]  Index Y: [(RTY)]  Index Z: [(MXEA)]  Allocation 1 [50%]  Allocation 2 [30%]  Allocation 3 [20%]  [6] Year[s] [10.00]% [12.00]% [100]%                                              

 

Athene Annuity and Life Company    SCS II (01/22) Page 5 SCS II (01/22)  [S&P 500® Price Return Index    The S&P 500® (the “Index”) is a product of S&P Dow Jones Indices LLC or its affiliates (“SPDJI”), and has been  licensed for use by Athene Annuity and Life Company. Standard & Poor’s® and S&P 500® are registered trademarks  of Standard & Poor’s Financial Services LLC (“S&P”); Dow Jones® is a registered trademark of Dow Jones  Trademark Holdings LLC (“Dow Jones”); and these trademarks have been licensed for use by SPDJI and  sublicensed for certain purposes by Athene Annuity and Life Company. It is not possible to invest directly in an  Index. Athene Annuity and Life Company’s Products are not sponsored, endorsed, sold or promoted by SPDJI, Dow  Jones, S&P, any of their respective affiliates (collectively, “S&P Dow Jones Indices”). S&P Dow Jones Indices makes  no representation or warranty, express or implied, to the owners of the Athene Annuity and Life Company’s Products  or any member of the public regarding the advisability of investing in securities generally or in Athene Annuity and  Life Company's products particularly or the ability of the S&P 500® to track general market performance. Past  performance of an Index is not an indication or guarantee of future results. S&P Dow Jones Indices’ only relationship  to Athene Annuity and Life Company with respect to the S&P 500® is the licensing of the S&P 500® and certain  trademarks, service marks and/or trade names of S&P Dow Jones Indices and/or its licensors. The S&P 500® is  determined, composed and calculated by S&P Dow Jones Indices without regard to Athene Annuity and Life  Company or the Athene Annuity and Life Company’s Products. S&P Dow Jones Indices have no obligation to take  the needs of Athene Annuity and Life Company or the owners of Athene Annuity and Life Company’s Products into  consideration in determining, composing or calculating the S&P 500®. S&P Dow Jones Indices are not responsible  for and have not participated in the determination of the prices, and amount of Athene Annuity and Life Company’s  products or the timing of the issuance or sale of Athene Annuity and Life Company’s Products or in the determination  or calculation of the equation by which Athene Annuity and Life Company’s products are to be converted into cash,  surrendered or redeemed, as the case may be. S&P Dow Jones Indices have no obligation or liability in connection  with the administration, marketing or trading of Athene Annuity and Life Company’s Products. There is no assurance  that investment products based on the S&P 500® will accurately track Index performance or provide positive  investment returns. S&P Dow Jones Indices LLC is not an investment advisor. Inclusion of a security within an Index  is not a recommendation by S&P Dow Jones Indices to buy, sell, or hold such security, nor is it considered to be  investment advice.  S&P DOW JONES INDICES DOES NOT GUARANTEE THE ADEQUACY, ACCURACY, TIMELINESS AND/OR  THE COMPLETENESS OF THE INDEX OR ANY DATA RELATED THERETO OR ANY COMMUNICATION,  INCLUDING BUT NOT LIMITED TO, ORAL OR WRITTEN COMMUNICATION (INCLUDING ELECTRONIC  COMMUNICATIONS) WITH RESPECT THERETO. S&P DOW JONES INDICES SHALL NOT BE SUBJECT TO  ANY DAMAGES OR LIABILITY FOR ANY ERRORS, OMISSIONS, OR DELAYS THEREIN. S&P DOW JONES  INDICES MAKE NO EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIMS ALL  WARRANTIES, OR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE OR AS TO  RESULTS TO BE OBTAINED BY ATHENE ANNUITY AND LIFE COMPANY, OWNERS OF THE ATHENE  ANNUITY AND LIFE COMPANY’S PRODUCTS, OR ANY OTHER PERSON OR ENTITY FROM THE USE OF  THE INDEX OR WITH RESPECT TO ANY DATA RELATED THERETO. WITHOUT LIMITING ANY OF THE  FOREGOING, IN NO EVENT WHATSOEVER SHALL S&P DOW JONES INDICES BE LIABLE FOR ANY  INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES INCLUDING BUT NOT  LIMITED TO, LOSS OF PROFITS, TRADING LOSSES, LOST TIME OR GOODWILL, EVEN IF THEY HAVE  BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, WHETHER IN CONTRACT, TORT, STRICT  LIABILITY, OR OTHERWISE. THERE ARE NO THIRD PARTY BENEFICIARIES OF ANY AGREEMENTS OR  ARRANGEMENTS BETWEEN S&P DOW JONES INDICES AND ATHENE ANNUITY AND LIFE COMPANY,  OTHER THAN THE LICENSORS OF S&P DOW JONES INDICES.] 

 

Athene Annuity and Life Company    SCS II (01/22) Page 6 SCS II (01/22)  [Russell 2000® Price Return Index  Athene annuity products (the “Products”) have been developed solely by Athene Annuity and Life Company. The  Products are not in any way connected to or sponsored, endorsed, sold or promoted by the London Stock Exchange  Group plc and its group undertakings (collectively, the “LSE Group”). FTSE Russell is a trading name of certain of  the LSE Group companies.   All rights in the Russell 2000 Index (the “Index”) vest in the relevant LSE Group company which owns the Index.  “Russell®” and “Russell 2000®” are trademarks of the relevant LSE Group company and are used by any other LSE  Group company under license.   The Index is calculated by or on behalf of FTSE International Limited or its affiliate, agent or partner. The LSE  Group does not accept any liability whatsoever to any person arising out of (a) the use of, reliance on or any error  in the Index or (b) investment in or operation of the Products. The LSE Group makes no claim, prediction, warranty  or representation either as to the results to be obtained from the Products or the suitability of the Index for the  purpose to which it is being put by Athene Annuity and Life Company.]    [MSCI EAFE Price Return Index  THIS PRODUCT IS NOT SPONSORED, ENDORSED, SOLD OR PROMOTED BY MSCI INC. (“MSCI”), ANY OF  ITS AFFILIATES, ANY OF ITS INFORMATION PROVIDERS OR ANY OTHER THIRD PARTY INVOLVED IN, OR  RELATED TO, COMPILING, COMPUTING OR CREATING ANY MSCI INDEX (COLLECTIVELY, THE “MSCI  PARTIES”).  THE MSCI INDEXES ARE THE EXCLUSIVE PROPERTY OF MSCI.  MSCI AND THE MSCI INDEX  NAMES ARE SERVICE MARK(S) OF MSCI OR ITS AFFILIATES AND HAVE BEEN LICENSED FOR USE FOR  CERTAIN PURPOSES BY ATHENE ANNUITY AND LIFE COMPANY.  NONE OF THE MSCI PARTIES MAKES  ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, TO THE ISSUER OR OWNERS OF THIS  PRODUCT OR ANY OTHER PERSON OR ENTITY REGARDING THE ADVISABILITY OF INVESTING IN  PRODUCTS GENERALLY OR IN THIS PRODUCT PARTICULARLY OR THE ABILITY OF ANY MSCI INDEX TO  TRACK CORRESPONDING STOCK MARKET PERFORMANCE.  MSCI OR ITS AFFILIATES ARE THE  LICENSORS OF CERTAIN TRADEMARKS, SERVICE MARKS AND TRADE NAMES AND OF THE MSCI  INDEXES WHICH ARE DETERMINED, COMPOSED AND CALCULATED BY MSCI WITHOUT REGARD TO  THIS PRODUCT OR THE ISSUER OR OWNERS OF THIS PRODUCT OR ANY OTHER PERSON OR ENTITY.   NONE OF THE MSCI PARTIES HAS ANY OBLIGATION TO TAKE THE NEEDS OF THE ISSUER OR OWNERS  OF THIS PRODUCT OR ANY OTHER PERSON OR ENTITY INTO CONSIDERATION IN DETERMINING,  COMPOSING OR CALCULATING THE MSCI INDEXES.  NONE OF THE MSCI PARTIES IS RESPONSIBLE FOR  OR HAS PARTICIPATED IN THE DETERMINATION OF THE TIMING OF, PRICES AT, OR QUANTITIES OF  THIS PRODUCT TO BE ISSUED OR IN THE DETERMINATION OR CALCULATION OF THE EQUATION BY OR  THE CONSIDERATION INTO WHICH THIS PRODUCT IS REDEEMABLE.  FURTHER, NONE OF THE MSCI  PARTIES HAS ANY OBLIGATION OR LIABILITY TO THE ISSUER OR OWNERS OF THIS PRODUCT OR ANY  OTHER PERSON OR ENTITY IN CONNECTION WITH THE ADMINISTRATION, MARKETING OR OFFERING  OF THIS PRODUCT.   ALTHOUGH MSCI SHALL OBTAIN INFORMATION FOR INCLUSION IN OR FOR USE IN THE CALCULATION  OF THE MSCI INDEXES FROM SOURCES THAT MSCI CONSIDERS RELIABLE, NONE OF THE MSCI  PARTIES WARRANTS OR GUARANTEES THE ORIGINALITY, ACCURACY AND/OR THE COMPLETENESS  OF ANY MSCI INDEX OR ANY DATA INCLUDED THEREIN.  NONE OF THE MSCI PARTIES MAKES ANY  WARRANTY, EXPRESS OR IMPLIED, AS TO RESULTS TO BE OBTAINED BY THE ISSUER OF THE  PRODUCT, OWNERS OF THE PRODUCT, OR ANY OTHER PERSON OR ENTITY, FROM THE USE OF ANY  

 

Athene Annuity and Life Company    SCS II (01/22) Page 7 SCS II (01/22)  MSCI INDEX OR ANY DATA INCLUDED THEREIN.  NONE OF THE MSCI PARTIES SHALL HAVE ANY  LIABILITY FOR ANY ERRORS, OMISSIONS OR INTERRUPTIONS OF OR IN CONNECTION WITH ANY MSCI  INDEX OR ANY DATA INCLUDED THEREIN. FURTHER, NONE OF THE MSCI PARTIES MAKES ANY  EXPRESS OR IMPLIED WARRANTIES OF ANY KIND, AND THE MSCI PARTIES HEREBY EXPRESSLY  DISCLAIM ALL WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, WITH  RESPECT TO EACH MSCI INDEX AND ANY DATA INCLUDED THEREIN.  WITHOUT LIMITING ANY OF THE  FOREGOING, IN NO EVENT SHALL ANY OF THE MSCI PARTIES HAVE ANY LIABILITY FOR ANY DIRECT,  INDIRECT, SPECIAL, PUNITIVE, CONSEQUENTIAL OR ANY OTHER DAMAGES (INCLUDING LOST  PROFITS) EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES.  No purchaser, seller or holder of this product, or any other person or entity, should use or refer to any MSCI trade  name, trademark or service mark to sponsor, endorse, market or promote this product without first contacting MSCI  to determine whether MSCI’s permission is required.  Under no circumstances may any person or entity claim any  affiliation with MSCI without the prior written permission of MSCI.]  [Nasdaq-100® Price Return Index    The Product(s) is not sponsored, endorsed, sold or promoted by Nasdaq, Inc. or its affiliates (Nasdaq, with its  affiliates, are referred to as the “Corporations”). The Corporations have not passed on the legality or suitability of, or  the accuracy or adequacy of descriptions and disclosures relating to, the Product(s). The Corporations make no  representation or warranty, express or implied to the owners of the Product(s) or any member of the public regarding  the advisability of investing in securities generally or in the Product(s) particularly, or the ability of the Nasdaq-100®  Index to track general stock market performance. The Corporations' only relationship to Athene Annuity and Life  Company (“Licensee”) is in the licensing of the Nasdaq®, Nasdaq-100®, and Nasdaq-100® Index, and certain trade  names of the Corporations and the use of the Nasdaq-100® Index which is determined, composed and calculated  by Nasdaq without regard to Licensee or the Product(s). Nasdaq has no obligation to take the needs of the Licensee  or the owners of the Product(s) into consideration in determining, composing or calculating the Nasdaq-100® Index.  The Corporations are not responsible for and have not participated in the determination of the timing of, prices at, or  quantities of the Product(s) to be issued or in the determination or calculation of the equation by which the Product(s)  is to be converted into cash. The Corporations have no liability in connection with the administration, marketing or  trading of the Product(s).    THE CORPORATIONS DO NOT GUARANTEE THE ACCURACY AND/OR UNINTERRUPTED CALCULATION OF  NASDAQ-100® INDEX OR ANY DATA INCLUDED THEREIN. THE CORPORATIONS MAKE NO WARRANTY,  EXPRESS OR IMPLIED, AS TO RESULTS TO BE OBTAINED BY LICENSEE, OWNERS OF THE PRODUCT(S)  OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE NASDAQ-100® INDEX OR ANY DATA  INCLUDED THEREIN. THE CORPORATIONS MAKE NO EXPRESS OR IMPLIED WARRANTIES, AND  EXPRESSLY DISCLAIM ALL WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR  PURPOSE OR USE WITH RESPECT TO THE NASDAQ-100® INDEX OR ANY DATA INCLUDED THEREIN.  WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT SHALL THE CORPORATIONS HAVE ANY  LIABILITY FOR ANY LOST PROFITS OR SPECIAL, INCIDENTAL, PUNITIVE, INDIRECT, OR CONSEQUENTIAL  DAMAGES, EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES.]    [Shiller Barclays CAPE® US Mid-Month Sector TR Net Index  The Shiller Barclays CAPE® US Mid-Month Sector TR Net Index (the “Index”) has been developed in part by RSBB- I, LLC, the research principal of which is Robert J. Shiller. RSBB-I, LLC is not an investment advisor, and does not  guarantee the accuracy or completeness of the the Index, or any data or methodology either included therein or  

 

Athene Annuity and Life Company    SCS II (01/22) Page 8 SCS II (01/22)  upon which it is based. Neither RSBB-I, LLC nor Robert J. Shiller and its consultant, IndexVestLAB, LLC and  consultants thereto, shall have any liability for any errors, omissions, or interruptions therein, and makes no  warranties, express or implied, as to performance or results experienced by any party from the use of any information  included therein or upon which it is based, and expressly disclaims all warranties of merchantability or fitness for a  particular purpose with respect thereto, and shall not be liable for any claims or losses of any nature in connection  with the use of such information, including but not limited to, lost profits or punitive or consequential damages, even  if RSBB-I, LLC is advised of the possibility of same.  Neither Barclays Bank PLC ("BB PLC") nor any of its affiliates (collectively "Barclays") is the issuer or producer of.  Athene Annuity and Life Company’s (“Athene”) annuity products (the “Products”) and Barclays has no  responsibilities, obligations or duties to purchasers of the Products. The Index, together with any Barclays Indices  that are components of the Index, is a trademark owned by Barclays and, together with any component Indices and  index data, is licensed for use by Athene as the issuer or producer of the Products (the "Issuer").   Barclays’ only relationship with the Issuer in respect of the the Index is the licensing of the the Index, which is  administered, compiled and published by BB PLC in its role as the Index sponsor (the "Index Sponsor") without  regard to the Issuer or the Products or purchasers of the Products. Additionally, Athene as issuer or producer of the  Products may for itself execute transaction(s) with Barclays in or relating to the Index in connection with the Products.  Consumers acquire the Products from Athene and neither acquire any interest in the Index nor enter into any  relationship of any kind whatsoever with Barclays upon purchasing the Products. The Products are not sponsored,  endorsed, sold or promoted by Barclays and Barclays makes no representation regarding the advisability of the  Products or use of the Index or any data included therein. Barclays shall not be liable in any way to the Issuer,  purchasers of the Products or to other third parties in respect of the use or accuracy of the Index or any data included  therein.  Barclays Index Administration (“BINDA”), a distinct function within BB PLC, is responsible for day-to-day governance  of BB PLC’s activities as Index Sponsor.  To protect the integrity of Barclays’ Indices, BB PLC has in place a control framework designed to identify and  remove and/or mitigate (as appropriate) conflicts of interest. Within the control framework, BINDA has the following  specific responsibilities:  • oversight of any third party Index calculation agent;  • acting as approvals body for Index lifecycle events (Index launch, change and retirement); and  • resolving unforeseen Index calculation issues where discretion or interpretation may be required (for  example: upon the occurrence of market disruption events).  To promote the independence of BINDA, the function is operationally separate from BB PLC’s sales, trading and  structuring desks, investment managers, and other business units that have, or may be perceived to have, interests  that may conflict with the independence or integrity of Barclays’ Indices.  Notwithstanding the foregoing, potential conflicts of interest exist as a consequence of BB PLC providing Indices  alongside its other businesses. Please note the following in relation to Barclays’ Indices:  • BB PLC may act in multiple capacities with respect to a particular Index including, but not limited to,  functioning as Index sponsor, Index administrator, Index owner and licensor.  • Sales, trading or structuring desks in BB PLC may launch products linked to the performance of a Index.  These products are typically hedged by BB PLC’s trading desks. In hedging an Index, a trading desk may  purchase or sell constituents of that Index. These purchases or sales may affect the prices of the Index  constituents which could in turn affect the level of that Index.  

 

Athene Annuity and Life Company    SCS II (01/22) Page 9 SCS II (01/22)  • BB PLC may establish investment funds that track an Index or otherwise use an Index for portfolio or asset  allocation decisions.  The Index Sponsor is under no obligation to continue the administration, compilation and publication of the Index or  the level of the Index. While the Index Sponsor currently employs the methodology ascribed to the Index (and  application of such methodology shall be conclusive and binding), no assurance can be given that market, regulatory,  juridical, financial, fiscal or other circumstances (including, but not limited to, any changes to or any suspension or  termination of or any other events affecting any constituent within the Index) will not arise that would, in the view of  the Index Sponsor, necessitate an adjustment, modification or change of such methodology. In certain  circumstances, the Index Sponsor may suspend or terminate the Index. The Index Sponsor has appointed a third- party agent (the "Index Calculation Agent") to calculate and maintain the Index. While the Index Sponsor is  responsible for the operation of the Index, certain aspects have thus been outsourced to the Index Calculation Agent.  Barclays   • makes no representation or warranty, express or implied, to the Issuer or any member of the public regarding  the advisability of investing in transactions generally or the ability of the Index to track the performance of  any market or underlying assets or data; and   • has no obligation to take the needs of the Issuer into consideration in administering, compiling or publishing  the Index.  Barclays has no obligation or liability in connection with administration, marketing or trading of the Products.   The licensing agreement between Athene and BB PLC is solely for the benefit of Athene and Barclays and not for  the benefit of the owners of the Products or other third parties.  BARCLAYS DOES NOT GUARANTEE, AND SHALL HAVE NO LIABILITY TO THE PURCHASERS AND  TRADERS, AS THE CASE MAY BE, OF THE TRANSACTION OR TO THIRD PARTIES FOR THE QUALITY,  ACCURACY AND/OR COMPLETENESS OF THE INDEX OR ANY DATA INCLUDED THEREIN OR FOR  INTERRUPTIONS IN THE DELIVERY OF THE INDEX. BARCLAYS MAKES NO EXPRESS OR IMPLIED  WARRANTIES, AND HEREBY EXPRESSLY DISCLAIMS ALL WARRANTIES OF MERCHANTABILITY OR  FITNESS FOR A PARTICULAR PURPOSE OR USE WITH RESPECT TO THE INDEX INCLUDING, WITHOUT  LIMITATION, THE INDICES, OR ANY DATA INCLUDED THEREIN. IN NO EVENT SHALL BARCLAYS HAVE ANY  LIABILITY FOR ANY SPECIAL, PUNITIVE, INDIRECT, OR CONSEQUENTIAL DAMAGES, OR ANY LOST  PROFITS, EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES SAVE TO THE EXTENT THAT SUCH  EXCLUSION OF LIABILITY IS PROHIBITED BY LAW.  None of the information supplied by Barclays and used in this publication may be reproduced in any manner without  the prior written permission of Barclays Bank PLC. Barclays Bank PLC is registered in England No. 1026167.  Registered office 1 Churchill Place London E14 5HP.]      Blaine T. Doerrfeld  Secretary    

 

Fixed Strategy Endorsement                                                                  Athene Annuity and Life Company    Fixed II (01/22) Page 1  Fixed II (01/22)  Fixed Strategy Endorsement    General Endorsement Provisions  Fixed Segment Options  This endorsement establishes one or more “Fixed Segment Options” for your Contract. The available  Fixed Segment Options are shown on the Segment Contract Schedule.  Part of the Contract  This endorsement is part of your Contract and is subject to all terms and conditions of your Contract.  Any capitalized terms not defined in this endorsement are defined in the Contract. To the extent  there are any conflicts between this endorsement and your Contract, this endorsement will control.  The effective date of this endorsement for new Contracts is the Contract Date and for existing  Contracts is the date we issue this endorsement.   Segment Value  Segment Value  The Segment Value for any Fixed Segment Option on the initial Segment Start Date is the amount  of the Holding Account allocated to the Segment Option.   On any other date, the Segment Value for any Fixed Segment Option is equal to A + B + C – D – E,  where:  A is the Segment Value as of the previous day;   B is the amount of Segment Credits that are credited to this Fixed Segment Option on  this date;  C is any amount transferred from your Contract’s other Segment Options to this Fixed  Segment Option on this date; and  D is any amount transferred from this Fixed Segment Option to your Contract’s other  Segment Options on this date.  E is any Withdrawals deducted on this date from this Fixed Segment Option;    The Segment Value may be reduced by any premium taxes as provided for in the Premium Taxes  section of your Contract. 

 

Fixed Strategy Endorsement                                                                  Athene Annuity and Life Company    Fixed II (01/22) Page 2  Fixed II (01/22)  Segment Credits  Segment Credits are credited to this Fixed Segment Option daily in a compounding fashion in  accordance with the initial Annual Interest Rate or renewal Annual Interest Rate and based on a  365-day year. The initial Annual Interest Rate is guaranteed for the initial Segment Term Period. At  the end of the initial Segment Term Period and any subsequent Segment Term Periods, we will  declare a renewal Annual Interest Rate. The initial Annual Interest Rate and the renewal Annual  Interest Rate are guaranteed not to be less than the Minimum Annual Interest Rate. The Minimum  Annual Interest Rate is shown on the Segment Contract Schedule.       Blaine T. Doerrfeld  Secretary                                    

 

Buffer Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer II (01/22) Page 1  Buffer II (01/22)  Buffer Strategy Endorsement    General Endorsement Provisions  Buffer Segment Options  This endorsement establishes one or more “Buffer Segment Options” for your Contract. Each Buffer  Segment Option will have an Index, Segment Term Period, [Segment Fee,] Cap Rate, [Annual  Spread,] Participation Rate, and Buffer Rate. The available Buffer Segment Options are shown on  the Segment Contract Schedule.  Buffer Segment Options with a Segment Start Date after the last day of the Withdrawal Charge  Period will be limited to one-year Segment Term Periods. Unless you instruct otherwise, the  Segment Value of any two-year Buffer Segment Option expiring on or after the last day of the  Withdrawal Charge Period will automatically transfer on its Segment End Date to its one-year  counterpart, if available. If a one-year counterpart is not available, that Segment Value will transfer  to the Fixed Segment Option with the shortest Segment Term Period. Buffer Segment Options with  a six-year Segment Term Period are available only during the first Contract Year. If you do not  request a transfer of the Segment Value of an expiring Segment Option with a six-year Segment  Term Period or withdraw the Segment Value, we will transfer the Segment Value to the Fixed  Segment Option with the shortest Segment Term Period.  Part of the Contract  This endorsement is part of your Contract and is subject to all terms and conditions of your Contract.  Any capitalized terms not defined in this endorsement are defined in the Contract. To the extent  there are any conflicts between this endorsement and your Contract, this endorsement will control.  The effective date of this endorsement for new Contracts is the Contract Date and for existing  Contracts is the date we issue this endorsement.   Definitions    Index Price  The Index Price for any date is the closing price of the Index on that date. The closing price of the  Index is the price determined and published by the provider of the Index at the end of each Business  Day. Any subsequent change in the reported price will not be reflected in the Index Price used to  calculate Segment Credits for the applicable Buffer Segment Option. If the Index Price for a Buffer  Segment Option is not available on any given day, then the Index Price as of the first preceding day  in which the Index Price is available will be utilized. The value of an Index may not include dividends  paid by the companies issuing the stocks comprising the Index.  Cap Rate  The Cap Rate is the maximum positive Index Change that may be used in the calculation of Segment  Credits. The initial Cap Rate is guaranteed for the first Segment Term Period only. A new Cap Rate  determined by us will become effective on each Segment Start Date. The Cap Rate for each Buffer  Segment Option is guaranteed to never be less than the Minimum Cap Rate shown on the Segment  Contract Schedule. 

 

Buffer Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer II (01/22) Page 2  Buffer II (01/22)    [Annual Spread  The Annual Spread is used in the calculation of Segment Credits. It is a percentage that is subtracted  from a positive Index Change after the Cap Rate is applied. The initial Annual Spread is guaranteed  for the first Segment Term Period only. A new Annual Spread determined by us will become effective  on each Segment Start Date. The Annual Spread for each Buffer Segment Option is guaranteed to  never be greater than the Maximum Annual Spread shown on the Segment Contract Schedule.]  Participation Rate  The Participation Rate is used in the calculation of Segment Credits. It is a percentage that is  multiplied by any positive Index Change after the Cap Rate is applied. The initial Participation Rate  is guaranteed for the first Segment Term Period only. A new Participation Rate determined by us will  be effective on each Segment Start Date. The Participation Rate for each Buffer Segment Option is  guaranteed to never be less than the Minimum Participation Rate shown on the Segment Contract  Schedule.   [Segment Fee  The Segment Fee is an annualized rate that is calculated on a daily basis as a percentage of that  Segment Option’s Segment Fee Base.  Starting on the Segment Start Date, We deduct the Segment  Fee amount daily from the Segment Value as long as the Segment Value for that Segment Option  is positive. The Segment Fee for all Buffer Segment Options is shown on the Segment Contract  Schedule and is guaranteed not to change.]  [Segment Fee Base  The initial Segment Fee Base is equal to the Segment Value on the Segment Start Date. The  Segment Fee Base on any other day is equal to the Segment Value on the Segment Start Date  reduced for any Withdrawals deducted from the Segment Option through the prior Business Day.]   Buffer Rate  The Buffer Rate is the amount of negative Index Change that we will absorb when calculating  Segment Credits. A negative Segment Credit will apply for any negative Index Change in excess of  the Buffer Rate. The Buffer Rate for each Buffer Segment Option is shown on the Segment Contract  Schedule and is guaranteed not to change.   Segment Value  Segment Value  The Segment Value for any Buffer Segment Option on the initial Segment Start Date is the amount  of the Holding Account allocated to that Segment Option.  [On any other date, the Segment Value for any Buffer Segment Option is equal to    A – B + C + D – E – F, where:  A is the Segment Value as of the previous day;   B is the Segment Fee amount applied to this Buffer Segment Option on this date;  C is the amount of Segment Credits that are credited to this Buffer Segment Option on  this date;  D is any amount transferred from your Contract’s other Segment Options to this Buffer  Segment Option on this date;     

 

Buffer Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer II (01/22) Page 3  Buffer II (01/22)    E is any amount transferred from this Buffer Segment Option to your Contract’s other  Segment Options on this date; and  F is any Withdrawals deducted from this Buffer Segment Option on this date.]    [On any other date, the Segment Value for any Buffer Segment Option is equal to    A + B + C – D – E, where:  A is the Segment Value as of the previous day;   B is the amount of Segment Credits that are credited to this Buffer Segment Option on  this date;  C is any amount transferred from your Contract’s other Segment Options to this Buffer  Segment Option on this date;   D is any amount transferred from this Buffer Segment Option to your Contract’s other  Segment Options on this date; and  E is any Withdrawals deducted from this Buffer Segment Option on this date.]    The Segment Value may be reduced by any premium taxes as provided for in the Premium Taxes  section of your Contract.  Segment Credits  Segment Credits, if any, will be calculated and added to a Buffer Segment Option only on a Segment  End Date.   On each Segment End Date, we will calculate the Index Change. The “Index Change” is equal to    (A / B) - 1, where:  A is the Index Price for the Segment End Date; and  B is the Index Price for the Segment Start Date.   [If the Index Change is greater than or equal to zero, then the “Segment Credit Percentage” on the  Segment End Date will be equal to the lesser of (1) or (2), where:  (1) = Greater of zero and B x [A – (D x E)];  (2) = Greater of zero and B x [C – (D x E)]; and where  A is the Index Change;  B is the Participation Rate;  C is the Cap Rate;  D is the Annual Spread; and  E is the number of years in the Segment Term Period.]  [If the Index Change is greater than or equal to zero, then the “Segment Credit Percentage” on the  Segment End Date will be equal to the lesser of (1) or (2), where:  (1) = Greater of zero and B x A;  (2) = Greater of zero and B x C; and where  A is the Index Change;  B is the Participation Rate; and  C is the Cap Rate.] 

 

Buffer Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer II (01/22) Page 4  Buffer II (01/22)    If the Index Change is less than zero, then the “Segment Credit Percentage” on the Segment End  Date will be equal to the lesser of zero and (A + B), where:  A is the Index Change; and  B is the Buffer Rate.  The amount of Segment Credits added to this Buffer Segment Option is equal to A x B, where:  A is the Segment Value as of the previous day; and  B is the Segment Credit Percentage.              Blaine T. Doerrfeld  Secretary                   

 

Buffer Multi-Index Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer MI II (01/22) Page 1  Buffer MI II (01/22)  Buffer Multi-Index Strategy Endorsement    General Endorsement Provisions  Buffer Multi-Index Segment Options  This endorsement establishes one or more “Buffer Multi-Index Segment Options” for your Contract.  Buffer Multi-Index Segment Options calculate an Aggregate Index Change based on three  underlying Indices rather than an Index Change based on a single underlying Index. Each Buffer  Multi-Index Segment Option will have Indices, Index Allocation Percentages, a Segment Term  Period, [a Segment Fee,] a Cap Rate, [an Annual Spread,] a Participation Rate, and a Buffer Rate.  The available Buffer Multi-Index Segment Options are shown on the Segment Contract Schedule.  Buffer Multi-Index Segment Options with a Segment Start Date after the last day of the Withdrawal  Charge Period will be limited to one-year Segment Term Periods. Unless you instruct otherwise, the  Segment Value of any two-year Buffer Multi-Index Segment Option expiring on or after the last day  of the Withdrawal Charge Period will automatically transfer on its Segment End Date to its one-year  counterpart, if available. If a one-year counterpart is not available, that Segment Value will transfer  to the Fixed Segment Option with the shortest Segment Term Period. Buffer Multi-Index Segment  Options with a six-year Segment Term Period are available only during the first Contract Year. If you  do not request a transfer of the Segment Value of an expiring Segment Option with a six-year  Segment Term Period or withdraw the Segment Value, we will transfer the Segment Value to the  Fixed Segment Option with the shortest Segment Term Period.  Part of the Contract  This endorsement is part of your Contract and is subject to all terms and conditions of your Contract.  Any capitalized terms not defined in this endorsement are defined in the Contract. To the extent  there are any conflicts between this endorsement and your Contract, this endorsement will control.  The effective date of this endorsement for new Contracts is the Contract Date and for existing  Contracts is the date we issue this endorsement.   Definitions  Index Price  The Index Price for any date is the closing price of the Index on that date. The closing price of the  Index is the price determined and published by the provider of the Index at the end of each Business  Day. Any subsequent change in the reported price will not be reflected in the Index Price used to  calculate Segment Credits for the applicable Buffer Multi-Index Segment Option. If the Index Price  for a Buffer Multi-Index Segment Option is not available on any given day, then the Index Price as  of the first preceding day in which the Index Price is available will be utilized. The value of an Index  may not include dividends paid by the companies issuing the stocks comprising the Index.  Cap Rate  The Cap Rate is the maximum positive Aggregate Index Change that may be used in the calculation  of Segment Credits. The initial Cap Rate is guaranteed for the first Segment Term Period only. A  new Cap Rate determined by us will become effective on each Segment Start Date. The Cap Rate  for each Buffer Multi-Index Segment Option is guaranteed to never be less than the Minimum Cap  Rate shown on the Segment Contract Schedule. 

 

Buffer Multi-Index Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer MI II (01/22) Page 2  Buffer MI II (01/22)  [Annual Spread  The Annual Spread is used in the calculation of Segment Credits. It is a percentage that is subtracted  from a positive Aggregate Index Change after the Cap Rate is applied. The initial Annual Spread is  guaranteed for the first Segment Term Period only. A new Annual Spread determined by us will  become effective on each Segment Start Date. The Annual Spread for each Buffer Multi-Index  Segment Option is guaranteed to never be greater than the Maximum Annual Spread shown on the  Segment Contract Schedule.]  Participation Rate  The Participation Rate is used in the calculation of Segment Credits. It is a percentage that is  multiplied by any positive Aggregate Index Change after the Cap Rate is applied. The initial  Participation Rate is guaranteed for the first Segment Term Period only. A new Participation Rate  determined by us will be effective on each Segment Start Date. The Participation Rate for each  Buffer Multi-Index Segment Option is guaranteed to never be less than the Minimum Participation  Rate shown on the Segment Contract Schedule.   Index Allocation Percentages  The Index Allocation Percentage 1, Index Allocation Percentage 2, and Index Allocation Percentage  3 are used in the calculation of Segment Credits. These Index Allocation Percentages are shown on  the Segment Contract Schedule. They are guaranteed for the first Segment Term Period only. New  Index Allocation Percentages determined by us will become effective on each Segment Start Date.  The Index Allocation Percentages will never be less than 1% and their sum must equal 100%.   [Segment Fee  The Segment Fee is an annualized rate that is calculated on a daily basis as a percentage of that  Segment Option’s Segment Fee Base.  Starting on the Segment Start Date, We will deduct the  Segment Fee amount daily from the Segment Value as long as the Segment Value for that Segment  Option is positive. The Segment Fee for all Buffer Multi-Index Segment Options is shown on the  Segment Contract Schedule and is guaranteed not to change.]  [Segment Fee Base  The initial Segment Fee Base is equal to the Segment Value on the Segment Start Date. The  Segment Fee Base on any other day is equal to the Segment Value on the Segment Start Date  reduced for any Withdrawals deducted from the Segment Option through the prior Business Day.]  Buffer Rate  The Buffer Rate is the amount of negative Aggregate Index Change that we will absorb when  calculating Segment Credits. A negative Segment Credit will apply for any negative Aggregate Index  Change in excess of the Buffer Rate. The Buffer Rate for each Buffer Multi-Index Segment Option  is shown on the Segment Contract Schedule and is guaranteed not to change.     Segment Value  Segment Value  The Segment Value for any Buffer Multi-Index Segment Option on the initial Segment Start Date is  the amount of the Holding Account allocated to that Segment Option. 

 

Buffer Multi-Index Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer MI II (01/22) Page 3  Buffer MI II (01/22)  [On any other date, the Segment Value for any Buffer Multi-Index Segment Option is equal to    A – B + C + D – E – F, where:  A is the Segment Value as of the previous day;   B is the Segment Fee amount applied to this Buffer Multi-Index Segment Option on this  date;  C is the amount of Segment Credits that are credited to this Buffer Multi-Index Segment  Option on this date;  D is any amount transferred from your Contract’s other Segment Options to this Buffer  Multi-Index Segment Option on this date;   E is any amount transferred from this Buffer Multi-Index Segment Option to your  Contract’s other Segment Options on this date; and  F is any Withdrawals deducted from this Buffer Multi-Index Segment Option on this date.]  [On any other date, the Segment Value for any Buffer Multi-Index Segment Option is equal to    A + B + C – D – E, where:  A is the Segment Value as of the previous day;   B is the amount of Segment Credits that are credited to this Buffer Multi-Index Segment  Option on this date;  C is any amount transferred from your Contract’s other Segment Options to this Buffer  Multi-Index Segment Option on this date;   D is any amount transferred from this Buffer Multi-Index Segment Option to your  Contract’s other Segment Options on this date; and  E is any Withdrawals deducted from this Buffer Multi-Index Segment Option on this date.]    The Segment Value may be reduced by any premium taxes as provided for in the Premium Taxes  section of your Contract.  Segment Credits  Segment Credits, if any, will be calculated and added to a Buffer Multi-Index Segment Option only  on a Segment End Date.   On each Segment End Date, we will calculate the Index Change for each Index. The “Index Change”  is equal to (A / B) - 1, where:  A is the Index Price for the Segment End Date; and  B is the Index Price for the Segment Start Date.   The Index Change will be calculated for Index X, Index Y, and Index Z shown on the Segment  Contract Schedule. Each Index Allocation Percentage will then be applied. The Index with the best  performing Index Change will be multiplied by the Index Allocation Percentage 1. The Index with the  second-best performing Index Change will be multiplied by the Index Allocation Percentage 2. The  Index with the third best performing Index Change will be multiplied by the Index Allocation  Percentage 3.  The resulting “Aggregate Index Change” will equal:  (Index Allocation Percentage 1 x Index Change for best performing Index) +   (Index Allocation Percentage 2 x Index Change for second best performing Index) +   (Index Allocation Percentage 3 x Index Change for third best performing Index). 

 

Buffer Multi-Index Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer MI II (01/22) Page 4  Buffer MI II (01/22)  [If the Aggregate Index Change is greater than or equal to zero, then the “Segment Credit  Percentage” on the Segment End Date will be equal to the lesser of (1) or (2), where:  (1) = Greater of zero and B x [A – (D x E)];  (2) = Greater of zero and B x [C – (D x E)]; and where  A is the Aggregate Index Change;  B is the Participation Rate;  C is the Cap Rate;   D is the Annual Spread; and  E is the number of years in the Segment Term Period.]  [If the Aggregate Index Change is greater than or equal to zero, then the “Segment Credit  Percentage” on the Segment End Date will be equal to the lesser of (1) or (2), where:  (1) = Greater of zero and B x A;  (2) = Greater of zero and B x C; and where  A is the Aggregate Index Change;  B is the Participation Rate; and  C is the Cap Rate.]    If the Aggregate Index Change is less than zero, then the “Segment Credit Percentage” on the  Segment End Date will be equal to the lesser of zero and (A + B), where:  A is the Aggregate Index Change; and  B is the Buffer Rate.  The amount of Segment Credits added to this Buffer Multi-Index Segment Option is equal to A x B,  where:  A is the Segment Value as of the previous day; and  B is the Segment Credit Percentage.      Blaine T. Doerrfeld  Secretary  

 

Buffer Milestone Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer MSTN II (01/22) Page 1  Buffer MSTN II (01/22)  Buffer Milestone Strategy Endorsement    General Endorsement Provisions  Buffer Milestone Segment Options  This endorsement establishes one or more “Buffer Milestone Segment Options” for your Contract.  Each Buffer Milestone Segment Option will have an Index, Segment Term Period, [Segment Fee,]  Cap Rate, Participation Rate, Milestone Threshold, Observation Interval, and Buffer Rate. The  available Buffer Milestone Segment Options are shown on the Segment Contract Schedule.   Buffer Milestone Segment Options are available only during the first Contract Year. If you do not  request a transfer of the Segment Value of an expiring Buffer Milestone Segment Option or withdraw  the Segment Value, we will transfer the Segment Value to the Fixed Segment Option with the  shortest Segment Term Period.    Part of the Contract  This endorsement is part of your Contract and is subject to all terms and conditions of your Contract.  Any capitalized terms not defined in this endorsement are defined in the Contract. To the extent  there are any conflicts between this endorsement and your Contract, this endorsement will control.  The effective date of this endorsement for new Contracts is the Contract Date and for existing  Contracts is the date we issue this endorsement.   Definitions  Index Price  The Index Price for any date is the closing price of the Index on that date. The closing price of the  Index is the price determined and published by the provider of the Index at the end of each Business  Day. Any subsequent change in the reported price will not be reflected in the Index Price used to  calculate any Milestone Index Change for the applicable Buffer Milestone Segment Option. If the  Index Price for a Buffer Milestone Segment Option is not available on any given day, then the Index  Price as of the first preceding day in which the Index Price is available will be utilized. The value of  an Index may not include dividends paid by the companies issuing the stocks comprising the Index.  Observation Date and Observation Interval  An Observation Date is a measuring point for calculating the Segment Credit. The first Observation  Date occurs one Observation Interval after the initial Milestone Date. Subsequent Observation Dates  occur one Observation Interval after the preceding Observation Date. The final Observation Date  will occur on the Segment End Date. The Observation Interval for each Buffer Milestone Segment  Option is shown on the Segment Contract Schedule and is guaranteed not to change.  Milestone Date   The Milestone Date is used to determine the beginning Index Price when determining the Milestone  Index Change. The initial Milestone Date is the Segment Start Date. If the Milestone Index Change  is greater than or equal to the Milestone Threshold at an Observation Date, a subsequent Milestone  Date will be established as of that Observation Date.      

 

Buffer Milestone Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer MSTN II (01/22) Page 2  Buffer MSTN II (01/22)  Milestone Index Change  The Milestone Index Change is the percentage change in the Index Price for the selected Buffer  Milestone Segment Option, as measured from the most recent Milestone Date to the current  Observation Date.  Milestone Threshold  The Milestone Threshold is the minimum Milestone Index Change needed in order to determine a  Milestone Credit Percentage for the selected Buffer Milestone Segment Option. The Milestone  Threshold for each Buffer Milestone Segment Option is shown on the Segment Contract Schedule  and is guaranteed not to change.  Milestone Credit Percentage  The Milestone Credit Percentage is used in the calculation of the Segment Credit and the Segment  Interim Value. If the Milestone Index Change is greater than or equal to the Milestone Threshold at  the current Observation Date, or if the Segment End Date is reached, a Milestone Credit Percentage  is determined based on the performance of the Index and the applicable Cap Rate, Participation  Rate, and Buffer Rate. The final Milestone Credit Percentage will be determined on the Segment  End Date.  Cap Rate  The Cap Rate is the maximum positive Milestone Index Change that may be used in the calculation  of the Milestone Credit Percentage. The Cap Rate for each Buffer Milestone Segment Option is  guaranteed to not be less than the Minimum Cap Rate shown on the Segment Contract Schedule.  Participation Rate  The Participation Rate is a percentage that is multiplied by any positive Milestone Index Change,  after the application of the Cap Rate, in the calculation of the Milestone Credit Percentage. The  Participation Rate for each Buffer Milestone Segment Option is guaranteed to not be less than the  Minimum Participation Rate shown on the Segment Contract Schedule.   [Segment Fee  The Segment Fee is an annualized rate that is calculated on a daily basis as a percentage of that  Segment Option’s Segment Fee Base.  Starting on the Segment Start Date, We will deduct the  Segment Fee amount daily from the Segment Value as long as the Segment Value for that Segment  Option is positive. The Segment Fee for all Buffer Milestone Segment Options is shown on the  Segment Contract Schedule and is guaranteed not to change.]  [Segment Fee Base  The initial Segment Fee Base is equal to the Segment Value on the Segment Start Date. The  Segment Fee Base on any other day is equal to the Segment Value on the Segment Start Date  reduced for any Withdrawals deducted from the Segment Option through the prior Business Day.]   Buffer Rate  The Buffer Rate is the amount of negative Milestone Index Change that we will absorb when  calculating the Milestone Credit Percentage. The Buffer Rate for each Buffer Milestone Segment  Option is shown on the Segment Contract Schedule and is guaranteed not to change.      

 

Buffer Milestone Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer MSTN II (01/22) Page 3  Buffer MSTN II (01/22)  Segment Value  Segment Value  The Segment Value for any Buffer Milestone Segment Option on the initial Segment Start Date is  the amount of the Holding Account allocated to that Segment Option.  [On any other date, the Segment Value for any Buffer Milestone Segment Option is equal to    A – B + C + D – E – F, where:  A is the Segment Value as of the previous day;   B is the Segment Fee amount applied to this Buffer Milestone Segment Option on this  date;  C is the amount of the Segment Credit that is credited to this Buffer Milestone Segment  Option on this date;  D is any amount transferred from your Contract’s other Segment Options to this Buffer  Milestone Segment Option on this date;   E is any amount transferred from this Buffer Milestone Segment Option to your Contract’s  other Segment Options on this date; and  F is any Withdrawals deducted from this Buffer Milestone Segment Option on this date.]    [On any other date, the Segment Value for any Buffer Milestone Segment Option is equal to    A + B + C – D – E, where:  A is the Segment Value as of the previous day;   B is the amount of the Segment Credit that is credited to this Buffer Milestone Segment  Option on this date;  C is any amount transferred from your Contract’s other Segment Options to this Buffer  Milestone Segment Option on this date;   D is any amount transferred from this Buffer Milestone Segment Option to your Contract’s  other Segment Options on this date; and  E is any Withdrawals deducted from this Buffer Milestone Segment Option on this date.]    The Segment Value may be reduced by any premium taxes as provided for in the Premium Taxes  section of your Contract.  Segment Credit  The Segment Credit, if any, will be calculated and added to a Buffer Milestone Segment Option only  on a Segment End Date.   On each Observation Date, we will calculate the Milestone Index Change. The Milestone Index  Change is equal to (A / B) - 1, where:  A is the Index Price for the current Observation Date; and  B is the Index Price for the most recent Milestone Date.       

 

Buffer Milestone Strategy Endorsement                                                                  Athene Annuity and Life Company     Buffer MSTN II (01/22) Page 4  Buffer MSTN II (01/22)  For Observation Dates other than the final Observation Date, a Milestone Credit Percentage will be  determined if the Milestone Index Change is greater than or equal to the Milestone Threshold. That  Milestone Credit Percentage will be equal to the lesser of (1) or (2), where:  (1) = B x A ;  (2) = B x C; and where  A is the Milestone Index Change;  B is the Participation Rate; and  C is the Cap Rate.  A Milestone Credit Percentage will be determined on the Segment End Date, regardless of the  Milestone Index Change. If on the Segment End Date the Milestone Index Change is greater than  or equal to zero, that Milestone Credit Percentage will be equal to the lesser of (1) or (2), where:  (1) = B x A;  (2) = B x C; and where  A is the Milestone Index Change;  B is the Participation Rate; and  C is the Cap Rate.  If on the Segment End Date the Milestone Index Change is less than zero, then that Milestone Credit  Percentage will be equal to the lesser of zero and (A + B), where:  A is the Milestone Index Change; and  B is the Buffer Rate.  The “Segment Credit Percentage” on the Segment End Date will be equal to the following:  1 Add one to each Milestone Credit Percentage; then  2 Multiply each of these sums together; then  3   Subtract one from the result.  The amount of the Segment Credit added to this Buffer Milestone Segment Option is equal to A x B,  where:  A is the Segment Value as of the previous day; and  B is the Segment Credit Percentage.            Blaine T. Doerrfeld  Secretary    

 

Bailout Endorsement                                                                  Athene Annuity and Life Company    Bailout II (01/22) Page 1  Bailout II (01/22)  Bailout Endorsement  Part of the Contract  This endorsement is part of your Contract and is subject to all terms, conditions, and provisions  contained in your Contract. Any capitalized terms not defined in this endorsement are defined in the  Contract or Strategy Endorsements. To the extent there are any conflicts between this endorsement  and your Contract, this endorsement will control. The effective date of this endorsement is the  Contract Date.   Definitions  Bailout Rates  A Bailout Rate is a type of threshold rate applicable for each Segment Option that is provided at the  time of application and printed in your Segment Contract Schedule. Fixed Segment Options have a  Bailout Annual Interest Rate and Index-Linked Segment Options have a Bailout Cap Rate and a  Bailout Participation Rate.   Initial Segment Term Period Bailout  Initial Segment Term Period Bailout   If as of the first Segment Start Date the declared Cap Rate, Participation Rate, or Annual Interest  Rate for a Segment Option in which you have funds is less than the applicable Bailout Rate specified  in your Segment Contract Schedule, you may cancel your Contract during the first [60 days] after  the Contract Date. You will receive your Purchase Payment less any Withdrawals without incurring  a Withdrawal Charge, Interest Adjustment, or Equity Adjustment.        Blaine T. Doerrfeld  Secretary             

 

Interim Value Endorsement                                                                  Athene Annuity and Life Company    Interim II (01/22) Page 1 Interim II (01/22)  Interim Value Endorsement  Part of the Contract  This endorsement is part of your Contract and is subject to all terms and conditions of your Contract.  Any capitalized terms not defined in this endorsement are defined in the Contract or Strategy  Endorsements. To the extent there are any conflicts between this endorsement and your Contract,  this endorsement will control. The effective date of this endorsement is the Contract Date.   Interim Value  Segment Interim Value  The Segment Interim Value for any Segment Option is calculated daily and is equal to A + B + C,  where:  A is the Segment Value on this date;   B is any applicable Interest Adjustment on this date; and  C is any applicable Equity Adjustment on this date.    Interest Adjustment  On any day, the Interest Adjustment for any Segment Option equals A x B, where:  A is the Segment Value on this date, immediately prior to any Withdrawal; and  B is the Interest Adjustment Factor.  Interest Adjustment Factor  The “Interest Adjustment Factor” for any Segment Option equals RN/12 - 1, where:  N is the number of complete months remaining before the Withdrawal Charge Period  expires; and   R  is equal to (1 + A) / (1 + B), where:  A is the Beginning Interest Adjustment Index Value; and  B is the Closing Interest Adjustment Index Value.  The “Beginning Interest Adjustment Index Value” is equal to the closing price of the Interest  Adjustment Index on the Contract Date. The “Closing Interest Adjustment Index Value” is equal to  the closing price of the Interest Adjustment Index on the day we calculate the Segment Interim Value.  If a closing price of the Interest Adjustment Index is not available on any day for which a closing price  is needed, then the closing price as of the first preceding Business Day for which a closing price is  available will be used. The “Interest Adjustment Index” is the [7 Year Point on the A Rated US  Bloomberg Fair Value Curve].  You may obtain the daily price of the Interest Adjustment Index by contacting us.   If the Interest Adjustment Index is discontinued, we are unable for any reason to utilize it, or the  calculation of the Interest Adjustment Index is changed substantially, we may substitute another  method of determining the values that will be used in the above calculation and will inform you of  that change at your last known address on file with us. Any substitute index will be submitted for  prior approval to the insurance regulatory authority of the state in which your Contract is issued.   

 

Interim Value Endorsement                                                                  Athene Annuity and Life Company    Interim II (01/22) Page 2 Interim II (01/22)  Equity Adjustment  On any day, except the Segment End Date, the Equity Adjustment for any Index-Linked Segment  Option equals A x B, where:  A is the Segment Value on this date, immediately prior to any Withdrawal; and  B is the Equity Adjustment Factor applicable to that Segment Option.  The Equity Adjustment is equal to zero on the Segment End Date. The Equity Adjustment does not  apply to Fixed Segment Options.  Equity Adjustment Factor  The “Equity Adjustment Factor” for Buffer Milestone Segment Options (if included in your Contract)  is equal to [A x (1 + C) + C] - [B x (1 - Y)], where:  A is the value of certain derivative instruments on the day we calculate the Segment  Interim Value;   B is the value of certain derivative instruments on the Segment Start Date for the  applicable Segment Option;   C is the result of the following calculation: add one to each Milestone Credit Percentage,  then multiply each of these sums together, then subtract one from the result; and  Y is the number of whole years elapsed from the Segment Start Date to the day we  calculate the Segment Interim Value, divided by the Segment Term Period.  The “Equity Adjustment Factor” for any other Index-Linked Segment Option is equal to                              A - B x (1 - Y), where:  A is the value of certain derivative instruments on the day we calculate the Segment  Interim Value;   B is the value of certain derivative instruments on the Segment Start Date for the  applicable Segment Option; and  Y is the number of whole years elapsed from the Segment Start Date to the day we  calculate the Segment Interim Value, divided by the Segment Term Period.  For Buffer Multi-Index Segment Options (if included in your Contract), the value of certain derivative  instruments for each of the underlying Indices is calculated independently and then weighted to  determine A and B in the Equity Adjustment Factor above. Weights are assigned based on the  relative value of the derivative instruments across the underlying Indices to produce an aggregate  derivative instrument value for the Buffer Multi-Index Segment Option. The weights are assigned as  follows:  • [50%] weight is assigned to the Index with the highest value of derivative instruments on the  date in question.  • [30%] weight is assigned to the Index with the second highest value of derivative instruments  on the date in question.  • [20%] weight is assigned to the Index with the lowest value of derivative instruments on the  date in question.  

 

Interim Value Endorsement                                                                  Athene Annuity and Life Company    Interim II (01/22) Page 3 Interim II (01/22)  On each Business Day, we calculate the value of the derivative instruments for each Index-Linked  Segment Option based on the estimated market value of a set of put and call options as determined  by an option pricing formula. You may obtain the Equity Adjustment Factor by contacting us.        Blaine T. Doerrfeld  Secretary    

 

Guaranteed Minimum Death Benefit Endorsement     Athene Annuity and Life Company  GMDB II (01/22) Page 1  GMDB II (01/22)  Guaranteed Minimum Death Benefit Endorsement  Part of the Contract  This endorsement is part of your Contract and is subject to all terms and conditions  of your Contract.  Any capitalized terms not defined in this endorsement are defined in the Contract. To the extent  there are any conflicts between this endorsement and your Contract, this endorsement will control.  The effective date of this endorsement for new Contracts is the Contract Date and for existing  Contracts is the date we issue this endorsement.   Death Benefit  If the amount of the Death Benefit provided under your Contract is less than the Return of Premium  Benefit, then the amount of the Death Benefit will be increased to equal the Return of Premium  Benefit.   Return of Premium Benefit  The “Return of Premium Benefit” is equal to A – B, where:  A is the Purchase Payment; and  B is the sum of net proceeds from all prior Withdrawals.    Net proceeds from prior Withdrawals are equal to the Contract Value withdrawn after the application  of Withdrawal Charges, Interest Adjustments, and Equity Adjustments.    [We do not treat the deduction of the Segment Fee as a Withdrawal.]  Death of Owner   This endorsement and all its provisions will terminate upon the date of death of the Owner (or the  Annuitant if the Owner is not a natural person) except as provided in the Spousal Continuation  section of this endorsement.  Spousal Continuation   If the surviving spouse of the deceased Owner (or the deceased Annuitant if the Owner is not a  natural person) is the Beneficiary and elects to continue your Contract, as provided for in the “Death  of an Owner prior to the Annuity Date” provision of your Contract, this endorsement and all its  provisions will also continue if the surviving spouse becomes the sole Annuitant and sole Owner of  your Contract.   Termination  The Owner may not elect to terminate this endorsement once it is effective. This endorsement will  terminate upon the earliest of the following dates:  1 the date on which we pay the Death Benefit;  2 the date on which your Contract is surrendered for its Cash Surrender Value;  3 the date the Withdrawal Charge Period ends;  4 the date the Owner changes or an additional Owner is added after the Contract Date,  unless the Contract is continued by the surviving spouse;  

 

Guaranteed Minimum Death Benefit Endorsement     Athene Annuity and Life Company  GMDB II (01/22) Page 2  GMDB II (01/22)  5 the date when the Owner is a non-natural person and the Annuitant changes or an  additional Annuitant is added after the Contract Date, unless the Contract is continued  by the surviving spouse.        Blaine T. Doerrfeld  Secretary

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}]]